US20070190021A1 - Poly(diallylamine)-based bile acid sequestrants - Google Patents
Poly(diallylamine)-based bile acid sequestrants Download PDFInfo
- Publication number
- US20070190021A1 US20070190021A1 US11/498,309 US49830906A US2007190021A1 US 20070190021 A1 US20070190021 A1 US 20070190021A1 US 49830906 A US49830906 A US 49830906A US 2007190021 A1 US2007190021 A1 US 2007190021A1
- Authority
- US
- United States
- Prior art keywords
- polymer
- group
- stirred
- minutes
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Poly(diallylamine) Polymers 0.000 title claims abstract description 97
- 229920000080 bile acid sequestrant Polymers 0.000 title description 4
- 229940096699 bile acid sequestrants Drugs 0.000 title description 3
- 229920000642 polymer Polymers 0.000 claims abstract description 334
- 238000000034 method Methods 0.000 claims abstract description 58
- 239000003613 bile acid Substances 0.000 claims abstract description 19
- 125000003118 aryl group Chemical group 0.000 claims abstract description 12
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 77
- 239000000178 monomer Substances 0.000 claims description 40
- 125000001424 substituent group Chemical group 0.000 claims description 22
- DYUWTXWIYMHBQS-UHFFFAOYSA-N n-prop-2-enylprop-2-en-1-amine Chemical compound C=CCNCC=C DYUWTXWIYMHBQS-UHFFFAOYSA-N 0.000 claims description 18
- 230000002209 hydrophobic effect Effects 0.000 claims description 16
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 125000003277 amino group Chemical group 0.000 claims description 11
- 229920006037 cross link polymer Polymers 0.000 claims description 9
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- 150000001450 anions Chemical class 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 125000006686 (C1-C24) alkyl group Chemical group 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 229920001519 homopolymer Polymers 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- 125000003368 amide group Chemical group 0.000 claims description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 3
- 125000001174 sulfone group Chemical group 0.000 claims description 3
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 125000004386 diacrylate group Chemical group 0.000 claims description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- 125000003375 sulfoxide group Chemical group 0.000 claims 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 claims 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 1
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 229960005261 aspartic acid Drugs 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 229960004365 benzoic acid Drugs 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 claims 1
- 229940097043 glucuronic acid Drugs 0.000 claims 1
- 229960002989 glutamic acid Drugs 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000011976 maleic acid Substances 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 229940098779 methanesulfonic acid Drugs 0.000 claims 1
- 235000006408 oxalic acid Nutrition 0.000 claims 1
- 229940116315 oxalic acid Drugs 0.000 claims 1
- 235000011007 phosphoric acid Nutrition 0.000 claims 1
- 229940107700 pyruvic acid Drugs 0.000 claims 1
- 229940032330 sulfuric acid Drugs 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 87
- 125000001165 hydrophobic group Chemical group 0.000 abstract description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 340
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 219
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 168
- 239000008367 deionised water Substances 0.000 description 115
- 229910021641 deionized water Inorganic materials 0.000 description 115
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 112
- 239000000243 solution Substances 0.000 description 98
- 238000003756 stirring Methods 0.000 description 89
- 239000000725 suspension Substances 0.000 description 88
- 239000011541 reaction mixture Substances 0.000 description 84
- 239000007787 solid Substances 0.000 description 58
- 239000011780 sodium chloride Substances 0.000 description 56
- 229910001868 water Inorganic materials 0.000 description 53
- 238000005804 alkylation reaction Methods 0.000 description 49
- 230000029936 alkylation Effects 0.000 description 47
- MYMSJFSOOQERIO-UHFFFAOYSA-N 1-bromodecane Chemical compound CCCCCCCCCCBr MYMSJFSOOQERIO-UHFFFAOYSA-N 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 41
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 38
- 239000002245 particle Substances 0.000 description 38
- 238000010438 heat treatment Methods 0.000 description 29
- 239000000499 gel Substances 0.000 description 27
- 238000001816 cooling Methods 0.000 description 26
- 239000000047 product Substances 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 22
- 238000001914 filtration Methods 0.000 description 22
- 229920002939 poly(N,N-dimethylacrylamides) Polymers 0.000 description 21
- 230000008569 process Effects 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 19
- 239000002904 solvent Substances 0.000 description 18
- ZTEHOZMYMCEYRM-UHFFFAOYSA-N 1-chlorodecane Chemical compound CCCCCCCCCCCl ZTEHOZMYMCEYRM-UHFFFAOYSA-N 0.000 description 17
- 238000003786 synthesis reaction Methods 0.000 description 17
- 239000002168 alkylating agent Substances 0.000 description 15
- 229940100198 alkylating agent Drugs 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 15
- FCQSEXGTTIULLO-UHFFFAOYSA-M 3-chloropropyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCCl FCQSEXGTTIULLO-UHFFFAOYSA-M 0.000 description 13
- SEKLFMRSNLFPRB-UHFFFAOYSA-N 2-(pyridin-2-yldisulfanyl)ethanamine;hydrochloride Chemical compound Cl.NCCSSC1=CC=CC=N1 SEKLFMRSNLFPRB-UHFFFAOYSA-N 0.000 description 12
- WGESLFUSXZBFQF-UHFFFAOYSA-N n-methyl-n-prop-2-enylprop-2-en-1-amine Chemical compound C=CCN(C)CC=C WGESLFUSXZBFQF-UHFFFAOYSA-N 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 10
- 239000003431 cross linking reagent Substances 0.000 description 10
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 9
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 description 8
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- JBJWASZNUJCEKT-UHFFFAOYSA-M sodium;hydroxide;hydrate Chemical compound O.[OH-].[Na+] JBJWASZNUJCEKT-UHFFFAOYSA-M 0.000 description 8
- ACYWYYRQTAEQFS-UHFFFAOYSA-M 4-chlorobutyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCCCl ACYWYYRQTAEQFS-UHFFFAOYSA-M 0.000 description 7
- 0 [1*][N+]1([2*])CC(C)CC(CC)C1.[1*][N+]1([2*])CC(CC)C(CC)C1 Chemical compound [1*][N+]1([2*])CC(C)CC(CC)C1.[1*][N+]1([2*])CC(CC)C(CC)C1 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 229960004132 diethyl ether Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 description 6
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- PNFHHKHSPWXENJ-UHFFFAOYSA-M 1-(3-chloropropyl)-1-dodecylpyrrolidin-1-ium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+]1(CCCCl)CCCC1 PNFHHKHSPWXENJ-UHFFFAOYSA-M 0.000 description 4
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 4
- KOFZTCSTGIWCQG-UHFFFAOYSA-N 1-bromotetradecane Chemical compound CCCCCCCCCCCCCCBr KOFZTCSTGIWCQG-UHFFFAOYSA-N 0.000 description 4
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 4
- WZKCTAJFWYZCBW-UHFFFAOYSA-M 3-chloropropyl-dimethyl-octadecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCl WZKCTAJFWYZCBW-UHFFFAOYSA-M 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000003999 initiator Substances 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- SGRHVVLXEBNBDV-UHFFFAOYSA-N 1,6-dibromohexane Chemical compound BrCCCCCCBr SGRHVVLXEBNBDV-UHFFFAOYSA-N 0.000 description 3
- VQMJCPAKKYJARO-UHFFFAOYSA-M 1-(3-chloropropyl)-1-decylpiperidin-1-ium;bromide Chemical compound [Br-].CCCCCCCCCC[N+]1(CCCCl)CCCCC1 VQMJCPAKKYJARO-UHFFFAOYSA-M 0.000 description 3
- GRAKHOCSWNZIPQ-UHFFFAOYSA-N 1-decylpiperidine Chemical compound CCCCCCCCCCN1CCCCC1 GRAKHOCSWNZIPQ-UHFFFAOYSA-N 0.000 description 3
- KULPYSCIHBMTQO-UHFFFAOYSA-M 4-chlorobutyl-decyl-diethylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](CC)(CC)CCCCCl KULPYSCIHBMTQO-UHFFFAOYSA-M 0.000 description 3
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000007738 vacuum evaporation Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- JVCRHTKQAPRUKG-UHFFFAOYSA-N 1-dodecylpyrrolidine Chemical compound CCCCCCCCCCCCN1CCCC1 JVCRHTKQAPRUKG-UHFFFAOYSA-N 0.000 description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 2
- SHQUQZLVNSGOOA-UHFFFAOYSA-M 6-chlorohexyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCCCCCl SHQUQZLVNSGOOA-UHFFFAOYSA-M 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 229920001268 Cholestyramine Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 125000002346 iodo group Chemical group I* 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000009103 reabsorption Effects 0.000 description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 125000001302 tertiary amino group Chemical group 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- SAWCWRKKWROPRB-UHFFFAOYSA-N 1,1-dibromohexane Chemical compound CCCCCC(Br)Br SAWCWRKKWROPRB-UHFFFAOYSA-N 0.000 description 1
- GTQHJCOHNAFHRE-UHFFFAOYSA-N 1,10-dibromodecane Chemical compound BrCCCCCCCCCCBr GTQHJCOHNAFHRE-UHFFFAOYSA-N 0.000 description 1
- MYWOJODOMFBVCB-UHFFFAOYSA-N 1,2,6-trimethylphenanthrene Chemical compound CC1=CC=C2C3=CC(C)=CC=C3C=CC2=C1C MYWOJODOMFBVCB-UHFFFAOYSA-N 0.000 description 1
- IDARFPSLQOHHJQ-UHFFFAOYSA-M 1-(3-chloropropyl)-1-dodecylpiperidin-1-ium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+]1(CCCCl)CCCCC1 IDARFPSLQOHHJQ-UHFFFAOYSA-M 0.000 description 1
- NIDSRGCVYOEDFW-UHFFFAOYSA-N 1-bromo-4-chlorobutane Chemical compound ClCCCCBr NIDSRGCVYOEDFW-UHFFFAOYSA-N 0.000 description 1
- MNDIARAMWBIKFW-UHFFFAOYSA-N 1-bromohexane Chemical compound CCCCCCBr MNDIARAMWBIKFW-UHFFFAOYSA-N 0.000 description 1
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 1
- RRMRPTOMFGARDV-UHFFFAOYSA-M 12-bromododecyl-decyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCBr RRMRPTOMFGARDV-UHFFFAOYSA-M 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- PTZRYAAOQPNAKU-UHFFFAOYSA-N 2-[(1-carboxy-3-cyanobutyl)diazenyl]-4-cyanopentanoic acid Chemical compound N#CC(C)CC(C(O)=O)N=NC(C(O)=O)CC(C)C#N PTZRYAAOQPNAKU-UHFFFAOYSA-N 0.000 description 1
- HPILSDOMLLYBQF-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COC(CCC)OCC1CO1 HPILSDOMLLYBQF-UHFFFAOYSA-N 0.000 description 1
- TURITJIWSQEMDB-UHFFFAOYSA-N 2-methyl-n-[(2-methylprop-2-enoylamino)methyl]prop-2-enamide Chemical compound CC(=C)C(=O)NCNC(=O)C(C)=C TURITJIWSQEMDB-UHFFFAOYSA-N 0.000 description 1
- BTNZIJNHZRKTDU-UHFFFAOYSA-N 2-methyl-n-[1-(2-methylprop-2-enoylamino)ethyl]prop-2-enamide Chemical compound CC(=C)C(=O)NC(C)NC(=O)C(C)=C BTNZIJNHZRKTDU-UHFFFAOYSA-N 0.000 description 1
- PIYJQTKZHLLZQE-UHFFFAOYSA-N 2-methyl-n-[2-(2-methylprop-2-enoylamino)ethyl]prop-2-enamide Chemical compound CC(=C)C(=O)NCCNC(=O)C(C)=C PIYJQTKZHLLZQE-UHFFFAOYSA-N 0.000 description 1
- VFZKVQVQOMDJEG-UHFFFAOYSA-N 2-prop-2-enoyloxypropyl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(=O)C=C VFZKVQVQOMDJEG-UHFFFAOYSA-N 0.000 description 1
- UVKTWFDHGDPIGF-UHFFFAOYSA-N 3-bromopropyl(tridecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCC[NH2+]CCCBr UVKTWFDHGDPIGF-UHFFFAOYSA-N 0.000 description 1
- WRQHALHMKQUJMU-UHFFFAOYSA-M 3-bromopropyl-dimethyl-nonylazanium;bromide Chemical compound [Br-].CCCCCCCCC[N+](C)(C)CCCBr WRQHALHMKQUJMU-UHFFFAOYSA-M 0.000 description 1
- RYNNSZKWDKFHCL-UHFFFAOYSA-M 3-bromopropyl-dimethyl-octylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCBr RYNNSZKWDKFHCL-UHFFFAOYSA-M 0.000 description 1
- MANIVFOGNGPSKT-UHFFFAOYSA-M 3-bromopropyl-docosyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)CCCBr MANIVFOGNGPSKT-UHFFFAOYSA-M 0.000 description 1
- YWWLWXAGAFDLHC-UHFFFAOYSA-M 3-bromopropyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCBr YWWLWXAGAFDLHC-UHFFFAOYSA-M 0.000 description 1
- AZEHPZVSUSSYBI-UHFFFAOYSA-M 3-bromopropyl-heptyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCC[N+](C)(C)CCCBr AZEHPZVSUSSYBI-UHFFFAOYSA-M 0.000 description 1
- KNWRUFVCYKUGQO-UHFFFAOYSA-M 3-chloropropyl-cyclohexyl-dimethylazanium;bromide Chemical compound [Br-].ClCCC[N+](C)(C)C1CCCCC1 KNWRUFVCYKUGQO-UHFFFAOYSA-M 0.000 description 1
- XCDVWZJDGLZKBZ-UHFFFAOYSA-M 3-chloropropyl-decyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCl XCDVWZJDGLZKBZ-UHFFFAOYSA-M 0.000 description 1
- NCCQZSRARYTGHW-UHFFFAOYSA-M 3-chloropropyl-didecyl-methylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(CCCCl)CCCCCCCCCC NCCQZSRARYTGHW-UHFFFAOYSA-M 0.000 description 1
- PPTXCAJGJJOOHG-UHFFFAOYSA-M 3-chloropropyl-dimethyl-octylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCCl PPTXCAJGJJOOHG-UHFFFAOYSA-M 0.000 description 1
- AANXHXIUHZYWHJ-UHFFFAOYSA-M 3-chloropropyl-dimethyl-tetradecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)CCCCl AANXHXIUHZYWHJ-UHFFFAOYSA-M 0.000 description 1
- YGQCYHAHJWUJQA-UHFFFAOYSA-M 3-chloropropyl-dimethyl-undecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCC[N+](C)(C)CCCCl YGQCYHAHJWUJQA-UHFFFAOYSA-M 0.000 description 1
- QVIYYENQXNJSRK-UHFFFAOYSA-M 3-chloropropyl-hexyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCC[N+](C)(C)CCCCl QVIYYENQXNJSRK-UHFFFAOYSA-M 0.000 description 1
- NOCABFCXUWNCKW-UHFFFAOYSA-M 3-chloropropyl-methyl-dioctylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCCCl)CCCCCCCC NOCABFCXUWNCKW-UHFFFAOYSA-M 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- ZEANSETUBDDANL-UHFFFAOYSA-M 3-iodobutyl-methyl-dioctylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCC(C)I)CCCCCCCC ZEANSETUBDDANL-UHFFFAOYSA-M 0.000 description 1
- XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- FHQFIPVLPMRBBR-UHFFFAOYSA-M 4-bromobutyl-methyl-dioctylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCCCBr)CCCCCCCC FHQFIPVLPMRBBR-UHFFFAOYSA-M 0.000 description 1
- QIMODWUMSAAZIK-UHFFFAOYSA-M 4-chlorobutyl-heptyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCC[N+](C)(C)CCCCCl QIMODWUMSAAZIK-UHFFFAOYSA-M 0.000 description 1
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 1
- BUBUZBFBYKUKMK-UHFFFAOYSA-M 6-bromohexyl-dimethyl-octylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCCCCBr BUBUZBFBYKUKMK-UHFFFAOYSA-M 0.000 description 1
- KDDCZDZRNPUXQK-UHFFFAOYSA-M 6-bromohexyl-dimethyl-undecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCC[N+](C)(C)CCCCCCBr KDDCZDZRNPUXQK-UHFFFAOYSA-M 0.000 description 1
- BYQRLLPYDSJZCP-UHFFFAOYSA-M 6-bromohexyl-docosyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCBr BYQRLLPYDSJZCP-UHFFFAOYSA-M 0.000 description 1
- VCEQXCJCJOTKMR-UHFFFAOYSA-M 6-chlorohexyl-dimethyl-octylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCCCCCl VCEQXCJCJOTKMR-UHFFFAOYSA-M 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- FHLPGTXWCFQMIU-UHFFFAOYSA-N [4-[2-(4-prop-2-enoyloxyphenyl)propan-2-yl]phenyl] prop-2-enoate Chemical compound C=1C=C(OC(=O)C=C)C=CC=1C(C)(C)C1=CC=C(OC(=O)C=C)C=C1 FHLPGTXWCFQMIU-UHFFFAOYSA-N 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- LPQVLIUFLWUMHG-UHFFFAOYSA-N acetyl 2-aminoacetate Chemical compound CC(=O)OC(=O)CN LPQVLIUFLWUMHG-UHFFFAOYSA-N 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical group N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 125000004429 atom Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- QUZSUMLPWDHKCJ-UHFFFAOYSA-N bisphenol A dimethacrylate Chemical compound C1=CC(OC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OC(=O)C(C)=C)C=C1 QUZSUMLPWDHKCJ-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- IRXBNHGNHKNOJI-UHFFFAOYSA-N butanedioyl dichloride Chemical compound ClC(=O)CCC(Cl)=O IRXBNHGNHKNOJI-UHFFFAOYSA-N 0.000 description 1
- RXKUYBRRTKRGME-UHFFFAOYSA-N butanimidamide Chemical compound CCCC(N)=N RXKUYBRRTKRGME-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- AAQUAAOHFUYIMI-UHFFFAOYSA-M decyl-dimethyl-(oxiran-2-ylmethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CC1CO1 AAQUAAOHFUYIMI-UHFFFAOYSA-M 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 229950010007 dimantine Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- UBOHYCDBALEWJC-UHFFFAOYSA-M dodecyl-dimethyl-[5-(4-methylphenyl)sulfonylpentyl]azanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCCCS(=O)(=O)C1=CC=C(C)C=C1 UBOHYCDBALEWJC-UHFFFAOYSA-M 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940097042 glucuronate Drugs 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
- BICAGYDGRXJYGD-UHFFFAOYSA-N hydrobromide;hydrochloride Chemical compound Cl.Br BICAGYDGRXJYGD-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 229940060367 inert ingredients Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- UFFQZCPLBHYOFV-UHFFFAOYSA-N n,n-diethyldecan-1-amine Chemical compound CCCCCCCCCCN(CC)CC UFFQZCPLBHYOFV-UHFFFAOYSA-N 0.000 description 1
- UUORTJUPDJJXST-UHFFFAOYSA-N n-(2-hydroxyethyl)prop-2-enamide Chemical compound OCCNC(=O)C=C UUORTJUPDJJXST-UHFFFAOYSA-N 0.000 description 1
- HADJJUAGACHKHO-UHFFFAOYSA-N n-(oxiran-2-ylmethyl)butanamide Chemical compound CCCC(=O)NCC1CO1 HADJJUAGACHKHO-UHFFFAOYSA-N 0.000 description 1
- XKWWQHSAOSKPJC-UHFFFAOYSA-N n-(oxiran-2-ylmethyl)hexanamide Chemical compound CCCCCC(=O)NCC1CO1 XKWWQHSAOSKPJC-UHFFFAOYSA-N 0.000 description 1
- JRRUOOPFYPGMAE-UHFFFAOYSA-N n-[1-(prop-2-enoylamino)ethyl]prop-2-enamide Chemical compound C=CC(=O)NC(C)NC(=O)C=C JRRUOOPFYPGMAE-UHFFFAOYSA-N 0.000 description 1
- AYGYHGXUJBFUJU-UHFFFAOYSA-N n-[2-(prop-2-enoylamino)ethyl]prop-2-enamide Chemical compound C=CC(=O)NCCNC(=O)C=C AYGYHGXUJBFUJU-UHFFFAOYSA-N 0.000 description 1
- NBJBNKUHAFKHSM-UHFFFAOYSA-N n-ethenylprop-2-en-1-amine Chemical compound C=CCNC=C NBJBNKUHAFKHSM-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229940039748 oxalate Drugs 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- HDMGAZBPFLDBCX-UHFFFAOYSA-M potassium;sulfooxy sulfate Chemical compound [K+].OS(=O)(=O)OOS([O-])(=O)=O HDMGAZBPFLDBCX-UHFFFAOYSA-M 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 238000007342 radical addition reaction Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- RHSGXFIUEVJFIW-UHFFFAOYSA-N trimethyl-[4-(oxiran-2-yl)butyl]azanium Chemical class C[N+](C)(C)CCCCC1CO1 RHSGXFIUEVJFIW-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G61/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G61/12—Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
Definitions
- Salts of bile acids act as detergents to solubilize and, consequently, aid in the digestion of, dietary fats.
- Bile acids are derived from cholesterol. Following digestion, bile acids can be passively absorbed in the jejunum or reabsorbed by active transport in the ileum. Bile acids which are not reabsorbed are deconjugated and dehydroxylated by bacterial action in the distal ileum and large intestine.
- One method of reducing the amount of bile acids that are reabsorbed is oral administration of compounds that sequester the bile acids and cannot themselves be absorbed.
- the sequestered bile acids consequently are excreted.
- Serum cholesterol is then employed to produce more bile acids, thereby lowering the serum cholesterol level of the patient.
- the present invention relates to a method for removing bile acids from a patient as well as certain polymers for use in the method.
- the method comprises the step of administering to the patient a therapeutically effective amount of a polymer characterized by a diallylamine monomer wherein the amino nitrogen atom bears at least one hydrophobic substituent.
- the hydrophobic substituent can be a substituted or unsubstituted, straight chain or branched C 3 -C 24 -alkyl group, a substituted or unsubstituted arylalkyl group or a substituted or unsubstituted aryl group.
- the polymer to be administered can be homopolymer or a copolymer.
- the polymer to be administered is a crosslinked or linear poly(diallylamine)polymer wherein at least 10% of the amino nitrogen atoms are substituted by a C 3 -C 24 -alkyl group.
- the polymer to be administered is characterized by a diallylamine monomer wherein the amino nitrogen atom bears an alkyl group which is substituted with a quaternary ammonium group. The nitrogen atom of the ammonium group can bear at least one terminal hydrophobic substituent.
- the polymer to be administered can comprise secondary amino groups, tertiary amino groups or quaternary ammonium groups or a combination thereof.
- Polymers which comprise secondary or tertiary amino groups can also be administered in the form of salts of a pharmaceutically acceptable acid.
- the polymer can be linear or crosslinked. In one embodiment, the polymer is crosslinked via the incorporation of a multifunctional comonomer. In another embodiment, the polymer is crosslinked via bridging groups which link amino nitrogen atoms on different polymer strands.
- the invention relates to poly(diallylamine)polymers which are useful as bile acid sequestrants. These polymers are characterized by an diallylamine monomer, or repeat unit, wherein the amino nitrogen bears an alkyl substituent which is substituted with an ammonium group.
- the polymer can be a homopolymer or a copolymer.
- the present invention offers the advantage that both substituted and unsubstituted diallylamines are readily polymerized and crosslinked, in comparison to other amine monomers. Such polymers also provide improved efficacy over polymers utilized in prior art methods.
- the present invention is based on Applicants' discovery that poly(diallylamine)polymers comprising hydrophobic groups exhibit excellent bile acid sequestration activity.
- the invention provides a method for removing bile acids from a patient comprising administering to the patient a therapeutically effective amount of a polymer characterized by a diallylamine monomer, or repeat unit, wherein the amino nitrogen atom bears a hydrophobic substituent.
- the term “therapeutically effective amount” refers to an amount which is sufficient to remove a significant quantity of bile acids from the patient and, thus, to lower the serum cholesterol level of the patient.
- the patient can be an animal, for example, a mammal, or a human.
- hydrophobic substituent is a moiety which, as a separate entity, is more soluble in octanol than water.
- the octyl (C 8 H 17 ) group is hydrophobic because its parent alkane, octane, has greater solubility in octanol than in water.
- the hydrophobic substituent can be a saturated or unsaturated, substituted or unsubstituted hydrocarbon group.
- Such groups include susbstituted and unsubstituted, normal, branched or cyclic alkyl groups having 3 or more carbon atoms, substituted or unsubstituted arylalkyl or heteroarylalkyl groups and substituted or unsubstituted aryl or heteroaryl groups.
- the polymer to be administered is a poly(diallylamine)polymer characterized by a diallylamine monomer wherein the amino nitrogen atom bears at least one hydrophobic substituent selected from the group consisting of substituted or unsubstituted, normal, branched or cyclic C 3 -C 24 -alkyl groups, such as a hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl or tetradecyl group; substituted or unsubstituted C 3 -C 24 -alkenyl groups, such as propenyl group; substituted or unsubstituted arylalkyl groups, such as a benzyl group; and substituted or unsubstituted aryl groups, such as a phenyl or naphthyl group.
- substituted or unsubstituted normal, branched or cyclic C
- Suitable alkyl substituents include halo (e.g. fluoro, chloro, bromo or iodo) groups, and alkoxy, cycloalkyl, substituted and unsubstituted, quaternary, amido, sulfone, sulfoxide, alkoxy and aryl groups.
- Suitable aryl and arylalkyl substituents include fluoro, chloro, bromo, iodo, amino, ammonioalkyl, alkyl, alkoxy, hydroxy, alkoxy, sulfoxide and sulfone groups.
- At least 10% of the amino nitrogen atoms within the polymer to be administered bear a hydrophobic substituent, such as a C 2 -C 24 -alkyl group.
- a hydrophobic substituent such as a C 2 -C 24 -alkyl group.
- at least about 40% of the amino nitrogen atoms can bear a hydrophobic substituent.
- poly(diallylamine)polymers are characterized by monomers, or repeat units, comprising five-membered rings, monomers comprising six-membered rings, or a combination thereof.
- the polymer to be administered is characterized by an ammonium-bearing monomer of Formula I or of Formula II or a combination thereof, wherein R 1 is a hydrophobic substituent, as described above, and R 2 is hydrogen, methyl, or a hydrophobic substituent.
- R 1 is selected from among the octyl, decyl and dodecyl groups and R 2 is methyl.
- X ⁇ is an anion, such as the conjugate base of a pharmaceutically acceptable acid.
- Such anions include chloride, citrate, tartrate, lactate, phosphate, hydrophosphate, methanesulfonate, acetate, formate, maleate, fumarate, malate, succinate, malonate, sulfate, hydrosulfate, L-glutamate, L-aspartate, pyruvate, mucate, benzoate, glucuronate, oxalate, ascorbate and acetylglycinate.
- X ⁇ is chloride.
- the polymer to be administered is characterized by an amine-bearing monomeric unit of Formula III or Formula IV or a combination thereof, wherein R is a hydrophobic substituent as previously described.
- the polymer to be administered comprises one or more monomers of Formulas I-IV wherein at least 10%, preferably at least about 20%, of the amino nitrogen atoms bear a C 3 -C 24 -alkyl substituent.
- C 3 -C 24 -alkyl groups include hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl and tetradecyl groups.
- the polymer to be administered can be a copolymer comprising one or more diallylamine monomers, such as one or more monomers of Formulas I, II, III, and IV, and at least one additional monomer.
- the additional monomer is sulfur dioxide.
- the polymer backbone includes —SO 2 — units between pairs of diallylamine monomers.
- the invention provides a method for removing bile acids from a patient comprising the step of administering to the patient a therapeutically effective amount of a polymer characterized by a diallylamine repeat unit wherein the amino nitrogen atom bears an ammonioalkyl substituent.
- the invention also includes the ammonioalkyl-substituted polymers which are of use in this method.
- ammonioalkyl refers to an alkyl group which is substituted by a nitrogen atom bearing three additional substituents.
- the nitrogen atom is an ammonium nitrogen atom which bears an alkylene substituent, which links this atom to the diallylamine nitrogen atom, and three additional substituents selected from among hydrogen, alkyl and arylalkyl.
- An ammonioalkyl group will further include a negatively charged counter ion, such as a conjugate base of a pharmaceutically acceptable acid.
- the diallylamine repeat unit can be, for example, of Formula I, Formula II, Formula III, or Formula IV, wherein at least one of the nitrogen substituents is an ammonioalkyl substituent.
- Suitable ammonioalkyl substituents are of the general formula wherein R 4 , R 5 and R 6 are each, independently, a hydrogen atom or a C 1 -C 24 alkyl group; n is an integer from 2 to about 20, preferably from 3 to about 6; and X ⁇ is an anion, such as a conjugate base of a pharmaceutically acceptable acid.
- at least one of R 4 , R 5 and R 6 is a hydrophobic group such as a C 3 -C 24 -alkyl group.
- R 4 , R 5 and R 6 is a C 6 -C 24 -alkyl group.
- Suitable examples of ammonioalkyl groups include, but are not limited to, 4-(dioctylmethylammonio)butyl; 3-(dodecyldimethylammonio)propyl; 3-(octyldimethylammonio)propyl; 3-(decyldimethylammonio)propyl; 5-(dodecyldimethylammonio)pentyl; 3-(cyclohexyldimethylammonio)propyl; 3-(decyldimethylammonio)-2-hydroxypropyl; 3-(tridecylammonio)propyl; 3-(docosyldimethylammonio)propyl; 4-(dodecyldimethylammonio)butyl; 3-(octadecyldimethylammonio)propyl;
- the polymer can be a homopolymer which comprises only a monomer selected from among Formulas I-IV, above, wherein the nitrogen atom bears at least one ammonioalkyl substituent.
- the polymer can also be a copolymer which comprises a monomer of this type and at least one additional monomer.
- the polymer can comprise a second diallylamine monomer wherein the nitrogen atom bears a substituent selected from among hydrogen, methyl, ethyl, hydrophobic groups and ammonioalkyl groups.
- the polymer can also comprise an additional monomer which is not a diallylamine.
- additional polymers include substituted and unsubstituted acrylate, acrylamide, methacrylate, methacrylamide, allylamine, allyl alcohol, vinyl amine and vinyl alcohol.
- the additional monomer can be a substituted acrylate or acrylamide which bears a hydrophobic group, such as a C 3 -C 24 -alkylacrylate or an N—C 3 -C 24 -alkylacrylamide.
- the additional monomer can also be a hydrophilic monomer, such as N-(2-hydroxyethyl)acrylamide or (3-hydroxypropyl)acrylate. Also included are the multifunctional crosslinking co-monomers which are discussed in detail below.
- the copolymers can have a wide range of compositions.
- the ammonioalkyl-substituted diallylamine monomer will constitute from about 10% to about 90% of the monomeric units composing the polymer.
- the polymers of use in the present method can be linear or crosslinked.
- the polymer can be crosslinked, for example, by the incorporation within the polymer of a multifunctional comonomer.
- Suitable multifunctional co-monomers include diacrylates, triacrylates and tetraacrylates, dimethacrylates, diacrylamides, diallylacrylamide and di(methacrylamides).
- ethylene glycol diacrylate propylene glycol diacrylate, butylene glycol diacrylate, ethylene glycol dimethacrylate, butylene glycol dimethacrylate, methylene bis(methacrylamide), ethylene bis(acrylamide), ethylene bis(methacrylamide), ethylidene bis(acrylamide), ethylidene bis(methacrylamide), pentaerythritol tetraacrylate, trimethylolpropane triacrylate, bisphenol A dimethacrylate, and bisphenol A diacrylate.
- suitable multifunctional monomers include polyvinylarenes, such as divinylbenzene.
- the amount of crosslinking agent is typically between 1.0% and 25% by weight relative to the weight of the polymer, preferably from about 2.5% to about 20% by weight and more preferably from about 2% to about 12% by weight.
- the polymer can also be crosslinked by bridging units which link amino groups on adjacent polymer strands.
- Suitable bridging units include straight chain or branched, substituted or unsubstituted alkylene groups, diacylalkylene groups, diacylarene groups and alkylene bis(carbamoyl) groups.
- Suitable bridging units include —(CH 2 ) n —, wherein n is an integer from about 2 to about 20; —CH 2 —CH(OH)—CH 2 —; —C(O)CH 2 CH 2 C(O)—; —CH 2 —CH(OH)—O—(CH 2 ) n —O—CH(OH)—CH 2 —, wherein n is 2 to about 4; —C(O)—(C 6 H 2 (COOH) 2 )—C(O)— and —C(O)NH(CH 2 ) p NHC(O)—, wherein p is an integer from about 2 to about 20.
- crosslinking the polymers renders the polymers non-adsorbable and stable in the patient.
- a “stable” polymer composition when administered in therapeutically effective amounts, does not dissolve or otherwise decompose to form potentially harmful byproducts, and remains substantially intact.
- Polymers of use in the present method are, preferably, of a molecular weight which enables them to reach and remain in the gastrointestinal tract for a sufficient period of time to bind a significant amount of one or more bile acids.
- the polymers should, thus, be of sufficiently high molecular weight to resist, partially or completely, absorption from the gastrointestinal tract into other regions of the body.
- the resulting polymer/bile salt complex should then be excreted from the body.
- Suitable linar (non-crosslinked) polymers have molecular weights which range from about 2,000 Daltons to about 500,000 Daltons, preferably from about 5,000 Daltons to about 150,000 Daltons.
- Crosslinked polymers are not generally characterized by molecular weight.
- the crosslinked polymers discussed herein should be sufficiently crosslinked to resist adsorption from the gastrointestinal tract.
- the polymer network can be administered orally to a patient in a dosage of about 1 mg/kg/day to about 10 g/kg/day; the particular dosage will depend on the individual patient (e.g., the patient's weight and the extent of bile salt removal required).
- the polymer can be administered either in hydrated or dehydrated form, and can be flavored or added to a food or drink, if desired, to enhance patient acceptance. Additional ingredients such as other bile acid sequestrants, drugs for treating hypercholesterolemia, atherosclerosis or other related indications, or inert ingredients, such as artificial coloring agents, may be added as well.
- suitable forms for administration include pills, tablets, capsules, and powders (i.e. for sprinkling on food).
- the pill, tablet, capsule or powder can be coated with a substance capable of protecting the composition from the gastric acid in the patient's stomach for a period of time sufficient for the composition to pass undisintegrated into the patient's small intestine.
- the polymer can be administered alone or in combination with a pharmaceutically acceptable carrier, diluent or excipient substance, such as a solid, liquid or semi-solid material.
- Suitable carriers, diluents and excipients include lactose, dextrose, sucrose, sorbitol, mannitol, starches, gum acacia, alginates, tragacanth, gelatin, calcium silicate, cellulose and others known in the art.
- Polymers of use in the present method can be prepared using techniques known in the art of polymer synthesis (see for example, Shalaby et al., ed., Water - Soluble Polymers, American Chemical Society, Washington D.C. (1991)).
- the appropriate monomer can be polymerized by methods known in the art, for example, via a free radical addition process.
- the polymerization mixture includes a free-radical initiator, such as a free radical initiator selected from among those which are well known in the art of polymer chemistry.
- Suitable free-radical initiators include azobis(isobutyronitrile), azobis(4-cyanovaleric acid), azobis(amidinopropane)dihydrochloride, potassium persulfate, ammonium persulfate and potassium hydrogen persulfate.
- the free radical initiator is preferably present in the reaction mixture in an amount ranging from about 0.1 mole percent to about 5 mole percent relative to the monomer.
- the polymer can be crosslinked, for example, by including a multifunctional co-monomer as the crosslinking agent in the reaction mixture.
- a multifunctional co-monomer can be incorporated into two or more growing polymer chains, thereby crosslinking the chains. Suitable multifunctional co-monomers include those discussed above.
- the amount of crosslinking agent added to the reaction mixture is, generally, between 1.0% and 25% by weight relative to the combined weight of the polymer and the crosslinking agent, and preferably from about 2.5% to about 20% by weight.
- the multifunctional co-monomer can also take the form of a multifunctional diallylamine, such as a bis(diallylamino)alkane or a bis(diallylalkylammonio)alkane.
- Suitable monomers of this type include 1,10-bis(diallylmethylammonio)decane dibromide and 1,6-bis(diallylmethylammonio)hexane, each of which can be formed by the reaction of diallylmethylamine with the appropriate dibromoalkane.
- the polymers to be administered can also be crosslinked subsequent to polymerization by reacting the polymer with one or more crosslinking agents having two or more functional groups, such as electrophilic groups, which react with amine groups to form a covalent bond.
- Crosslinking in this case can occur, for example, via nucleophilic attack of the polymer amino groups on the electrophilic groups. This results in the formation of a bridging unit which links two or more amino nitrogen atoms from different polymer strands.
- Suitable crosslinking agents of this type include compounds having two or more groups selected from among acyl chloride, epoxide, and alkyl-X, wherein X is a suitable leaving group, such as a halo, tosyl or mesyl group.
- crosslinking agent can also be an ⁇ , ⁇ -alkylene diisocyanate, for example OCN(CH 2 ) p NCO, wherein p is an integer from about 2 to about 20.
- the polymer can be reacted with an amount of crosslinking agent equal from about 0.5 and 20 mole percent relative to the amino groups within the polymer, depending upon the extent of crosslinking desired.
- a polymer comprising alkylated amino groups can be formed by reacting a preformed polymer with a suitable alkylating agent, or by polymerizing an alkylated monomer.
- Suitable alkylated monomers can be prepared by reacting diallylamine or a diallylamine derivative, such as diallylmethylamine, with an alkylating agent.
- diallylamine or a diallylamine derivative such as diallylmethylamine
- Suitable alkylating agents are compounds comprising an alkyl group or alkyl derivative which is bonded to a leaving group, such as a halo, tosylate, mesylate or epoxy group.
- a leaving group such as a halo, tosylate, mesylate or epoxy group.
- preferred alkylating agents include C 1 -C 24 -alkyl halides, for example, n-butyl halides, n-hexyl halides, n-decyl halides, and n-octadecyl halides; C 2 -C 24 -dihaloalkanes, for example, 1,10-dihalodecanes; C 1 -C 24 -hydroxyalkyl halides, for example, 11-halo-1-undecanols; C 1 -C 24 -arylalkyl halides, for example, benzyl halide; C 2 -C 24 -
- Diallylamine polymers having amino groups which bear quaternary ammonium-substituted alkyl groups can be prepared using alkylating agents such as (X— alkyl)ammonium salts, wherein X represents a suitable leaving group, as described above. These compounds can be prepared by the reaction of an appropriate dihaloalkane, such as a bromochloroalkane, with a tertiary amine. Suitable alkylating agents of this type include the following:
- alkylating agents described above can also exist and be used as a salt in combination with an anion other than bromide.
- these and similar alkylating agents can be prepared and used as salts with a wide range of anions, including chloride, iodide, acetate, p-toluenesulfonate and methanesulfonate.
- the extent of alkylation can be determined by methods which are well known in the chemical arts.
- the increase in polymer mass due to alkylation provides one measure of the extent of alkylation.
- a product/starting material mass ratio of about 3.0, 2.0 and 1.5 represent approximately 100%, 50% and 25% alkylation, respectively.
- the degree of alkylation can also be determined by elemental analysis of the product polymer. In this case, the carbon/nitrogen (C/N) mass ratio is a direct measure of the degree of alkylation.
- reaction of poly(diallyhnethylamine) with 1-bromodecane yields a product with a higher C/N mass ratio than that of the starting polymer.
- Product C/N mass ratios of about 6, 8.2, 10.6 and 14.6 represent, approximately, 0%, 25%, 50% and 100% alkylation, respectively.
- diallylmethylamine 100 g
- 1-bromododecane 249 g
- tetrahydrofuran 750 mL
- the mixture was heated to 65° C. for 44 h, and then allowed to cool to room temperature.
- the solvent was removed by rotary vacuum evaporation to leave two layers.
- Diethylether 500 mL was added and the mixture was stirred for 1 hr. The mixture was allowed to settle and the top layer was decanted and discarded. Additional diethylether (500 mL) was added.
- the mixture was stirred for 24 h, and the top layer was again decanted and discarded.
- the remaining oil was dried in a vacuum oven at 65° C. for 4 days to yield 67 g of product.
- diallylmethylamine 86.1 g
- 1,10-dibromodecane 112 g
- methanol 100 mL
- the mixture was heated to 65° C. for 24 h, and then allowed to cool to room temperature.
- the solvent was removed by rotary vacuum evaporation.
- Diethylether 400 mL was added and the mixture was stirred for 1 hr.
- the mixture was allowed to settle and the top layer was decanted and discarded.
- the remaining oil was dried by rotary vacuum evaporation to yield 215 g of product.
- the solid was collected by filtration and resuspended in methanol (250 mL). After stirring for 1 hr, the solid was collected by filtration and resuspended in aqueous NaCl (250 mL of 1.5 M solution). After again stirring for 1 hr, the solid was collected by filtration. The aqueous NaCl rinse was repeated twice more, and the solid was rinsed with water until the conductivity of the rinse reached 0.08 mS/cm. The solid was dried in a forced-air oven at 60° C. to yield 17.6 g of product.
- a crosslinked gel of N-methyl-N; N-diallylamine polymer was prepared by reacting the corresponding linear soluble polymer with epichlorohydrin.
- the starting material, poly(diallylmethylamine) was obtained in the form of its hydrochloride salt from Nitto Boseki Co.
- the polymer was obtained as a 60% aqueous solution (PAS-M-1, Lot #51017).
- the chemical process to obtain insoluble gels of this polymer involved partial neutralization of the amine hydrochloride polymer with a base followed by treatment with a predetermined amount of epichlorohydrin at room temperature.
- Experimental details to obtain a typical crosslinked gel of poly(diallylmethylamine hydrochloride) are given below.
- the swollen polymer particles were resuspended in 600 mL deionized water, stirred for 45 minutes and collected by filtration. The process was repeated with 800 mL water and 1 hr stirring. After filtration, the filtrate showed a conductivity of 4 mS/cm.
- the filtered polymer (swollen gel) was dried in a forced air oven at 60° C. to yield 42 g of product.
- the reaction mixture was stirred at 75° C. for an additional 18 hours, after which time heating was discontinued. After cooling to 30° C., 5 mL concentrated HCl was added and stirring was continued for 30 minutes. The pH of the medium dropped to 1.8.
- the polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. Polymer particles were suspended in 600 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL of 2 M NaCl solution and stirred for 40 minutes. The polymer was filtered and this process of NaCl treatment was repeated two more times.
- the filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes the polymer was filtered and resuspended in 700 mL deionized water and stirred for 30 minutes. Concentrated HCl (2 mL) was added to the suspension and the mixture was stirred for 15 minutes. The pH of the suspension was found to be 2.25. After stirring for an additional 20 minutes, the polymer was filtered and dried at 60° C. in a forced air oven, yielding 54.6 g of the alkylated polymer as a light yellow solid. The polymer was ground and passed through a 140 mesh sieve.
- the reaction mixture was stirred at 75° C. for an additional 18 h after which time the heating discontinued. After cooling to 30° C., concentrated HCl (2 mL) was added and the mixture was stirred for 30 minutes.
- the polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. Polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL 2M NaCl solution and stirred for 40 minutes. It was filtered and this process of NaCl treatment was repeated two more times. The filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water.
- the polymer was filtered and resuspended in 500 mL deionized water and stirred for 30 minutes. Concentrated HCl (2 mL) was added to the suspension and the mixture was stirred for 15 minutes. The pH of the suspension was found to be 2.2. After stirring for an additional 20 minutes, the polymer was filtered and dried at 60° C. in a forced air oven, yielding 18 g of the alkylated polymer as a pale white solid. The polymer was ground and passed through a 140 mesh sieve.
- (4-Chlorobutyl)dodecyldimethylammonium bromide and (6-chlorohexyl)dodecyldimethylammonium bromide can be prepared by a similar process using the appropriate bromochloroalkane and dodecyldimethylamine.
- a mixture of 11 g crosslinked polymer gel (Example 6) and 74 g (3-chloropropyl)-dimethyldodecylammonium bromide was dispersed in 250 mL deionized water and heated to 75° C. with stirring. After stirring at 75° C. for 15 minutes, 2 g of a 50% aqueous NaOH solution was added to the reaction mixture. After 2 hr, 1 g of NaOH solution was added followed by an additional 1 g after another 1 hr and the mixture was stirred at 75° C. for 23 hr. The reaction mixture was then allowed to cool. After cooling to 30° C., 3 mL concentrated HCl was added and the mixture was stirred for 30 minutes.
- the polymer was filtered and washed with 200 mL methanol.
- the filtered polymer particles were dispersed in 400 mL methanol and stirred for 45 minutes and filtered. This process was repeated one more time, then the filtered polymer was suspended in 500 mL 2M NaCl solution, stirred for 45 minutes and filtered. This process of NaCl treatment was repeated twice and the filtered polymer was suspended in 500 mL deionized water.
- the mixture was stirred for 45 minutes, filtered, resuspended in 400 mL deionized water and stirred for an additional 40 minutes.
- 1 mL concentrated HCl was added and the mixture was stirred for 20 minutes.
- the polymer was filtered and dried in a forced air oven at 60° C., yielding 29 g of alkylated polymer as a light yellow solid which was ground and passed through a 140 mesh sieve.
- a mixture of 10 g 3% crosslinked polymer gel (Example 6) and 76 g (4-chlorobutyl)dimethyldodecyl-ammonium bromide was dispersed in 250 mL deionized water and heated to 70° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH was then added to the reaction mixture. After 2 hr, 1 g NaOH solution was added followed by additional 1 g after another 2 hr. The reaction mixture was then stirred at 70° C. for 20 hours. 1 g NaOH was then added and the reaction mixture was kept at 70° C. After 20 hr heating, 1 g NaOH solution was added and the reaction mixture was kept at 70° C. with stirring for 2 hr.
- This example illustrates alkylation of the 4.5% crosslinked poly(diallylmethylamine) with different amounts of 1-bromodecane to obtain quaternized polyamines bearing varying amounts of hydrophobic groups.
- the polymer was treated with varying mole fractions of 1-bromodecane (1.0, 0.75, 0.50, 0.25 and 0.10).
- Table 1 summarizes amounts of 1-bromoalkane used to obtain polymers of varying degree of alkylation and the yield of alkylated polymer per gram of the 4.5% crosslinked poly(diallylmethylamine) (Example 2). This g/g yield is a measure of the degree of alkylation of the polymer.
- the polymer was filtered and washed with 200 mL deionized water and 200 mL methanol for 30 minutes and filtered. This process was repeated twice and the filtered polymer was suspended in 400 mL of 2M NaCl solution, stirred for 45 minutes and filtered. After repeating the NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for an additional 30 minutes, filtered, resuspended in 400 mL deionized water and stirred for an additional 40 minutes. To this polymer suspension was added 1 mL concentrated HCl and the mixture was stirred for 20 minutes.
- the polymer was filtered and this process of NaCl treatment was repeated twice.
- the filtered polymer cake was then washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes the polymer was filtered and resuspended in 500 mL deionized water and the suspension was stirred for 30 minutes. 1 mL concentrated HCl was then added to the suspension, which was stirred for another 55 minutes.
- the polymer was then filtered and dried at 60° C. in a forced air oven, yielding 22 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- the reaction mixture was allowed to stir at 75° C. for an additional 18 hours after which time the heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and stirring was continued for 30 minutes.
- the polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. Polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL 2M NaCl solution and the suspension was stirred for 40 minutes. The polymer was filtered and this process of NaCl treatment was repeated twice. The filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water.
- the polymer was filtered, resuspended in 500 mL deionized water, and stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension and stirred for 35 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 15.8 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- the reaction mixture was stirred at 75° C. for an additional 18 hours after which time the heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The pH of the medium at this point was 2.0.
- the polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. The polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL of 2 M NaCl solution and the suspension was stirred for 40 minutes. The polymer was filtered and this process of NaCl treatment was repeated twice.
- the filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes, the polymer was filtered, resuspended in 500 mL deionized water and stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension, which was stirred for 35 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 13.7 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- a mixture of 22 g diallylmethylamine and 74 g 3-chloropropyldodecyldimethylammonium bromide were dissolved in 100 mL methanol and the reaction mixture was stirred at 65° C. for 48 hours. The progress of the reaction was monitored by the disappearance of the dialllymethylamine by thin layer chromatography (TLC). After cooling to room temperature, the solvent was removed under reduced pressure. The residual viscous oil was precipitated into 800 mL dry ether with rapid stirring. The ether layer was decanted and the residue was again treated with 500 mL dry ether. After stirring for 15 minutes the solvent was removed and the oily residue was dried under vacuum at 35° C. for 48 hours, yielding 70 g of the product.
- TLC thin layer chromatography
- a mixture of 22 g diallylmethylamine and 75 g 4-chlorobutyldimethyldodecyl-ammonium bromide were dissolved in 100 mL methanol and the reaction mixture was stirred at 65° C. for 48 hours. The progress of the reaction was monitored by the disappearance of the diallylmethylamine by thin layer chromatography (TLC). After cooling to room temperature, the solvent was removed under reduced pressure. The residual viscous oil was precipitated into 800 mL dry ether with rapid stirring. The ether layer was decanted and the residue was again treated with 500 mL dry ether. After stirring for 15 minutes the solvent was removed and the oily residue was dried under vacuum at 35° C. for 48 hours, yielding 65 g of the product.
- TLC thin layer chromatography
- the residue was suspended in 200 mL methanol, stirred for 30 minutes and centrifuged.
- the residue was suspended in 300 mL methanol and the suspension was refluxed for 1 hr. After cooling to room temperature, the suspension was filtered and the white solid was dried at 60° C. for 24 hr to yield 10 g of the polymer.
- the polymer was ground and passed through 140 mesh sieve.
- the suspension was stirred for 1 hr and filtered.
- the swollen polymer particles were resuspended in 800 mL deionized water and stirred for 1.5 hr.
- the polymer particles were then filtered and dried in a forced air oven at 60° C. to yield 16 g of polymer.
- the dried polymer was ground and passed through a 10 mesh sieve.
- Example 20 The polymer (5 g) of Example 20 was placed in a 500 mL 3-necked round bottom flask and suspended in 100 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, a solution of 18 g 1-bromodecane in 100 mL ethanol was added and the reaction mixture stirred for 10 minutes. Subsequently, 2 g 50% aqueous sodium hydroxide was added and the reaction mixture was stirred at room temperature for 30 minutes followed by heating to 75° C. After 1 hr, 0.5 g NaOH solution was added followed by an additional 0.5 g of NaOH solution after another 1.5 hr. The reaction mixture was allowed to stir at 75° C.
- the polymer was filtered off and resuspended in 500 mL deionized water. The suspension was stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension and the suspension was stirred for 35 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 11.4 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- the polydiallylammonium chloride solution of Example 23 (150 g) was diluted with 50 mL deionized water. Solid NaOH (6.75 g) was added to the polymer solution with stirring. The reaction mixture was stirred until the NaOH has dissolved and temperature of the solution had dropped to below 30° C. To this partially neutralized polymer solution, epichlorohydrin (1.2 mL) was added and stirring was continued. The reaction medium slowly became increasingly viscous and after about 50 minutes it gelled and the stirring stopped. This gelled polymer was left at room temperature for an additional 48 hr to yield a semi-brittle polymer slab. The polymer slab was broken into smaller pieces and was dispersed in 1 L deionized water.
- the resulting suspension was stirred for 1.5 hr and then filtered.
- the swollen polymer particles were resuspended in 1 L deionized water and the suspension was stirred for 40 minutes.
- the polymer particles were filtered off and dried in a forced air oven at 60° C. to yield 56 g of pale white solid polymer.
- the dried polymer was ground and passed through a 10 mesh sieve.
- Example 23 The ground polymer of Example 23 (5 g) was placed in a 500 mL 3-necked round-bottomed flask and suspended in 100 mL deionized water and the suspension was stirred with a mechanical stirrer. To this swollen gel, a solution of 15 g 1-bromodecane in 100 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 2 g 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. Subsequently, an additional 4 g 50% NaOH was added in a 1 g batch at an interval of 1.5 hr (the base addition maintained a pH between 10 to 12). The reaction mixture was allowed to stir at 75° C.
- the polymer was filtered off and resuspended in 500 mL deionized water. The resulting suspension was stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension, which was then stirred for 35 minutes. The pH of the suspension was found to be 2.2. The polymer was then filtered off and dried at 60° C. in a forced air oven, yielding 13.3 g of the alkylated polymer as a pale white solid. The polymer was ground and passed through a 140 mesh sieve.
- a mixture of 5 g of the crosslinked polymer gel of Example 23 and 28 g (3-chloropropyl)dimethyl-dodecylammonium bromide was dispersed in 150 mL deionized water and the suspension was stirred. To this suspension 2 g 50% NaOH was added and the mixture was stirred for 15 minutes. The mixture was then heated with stirring to 75° C. An additional 4 g 50% NaOH was added in 1 g batches at 1.5 hr intervals (the base addition was such as to maintain the pH between 10 to 12). After stirring at 75° C. for a total period of 18 hr, the reaction mixture was allowed to cool. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes.
- the polymer particles were filtered off and washed with 200 mL methanol.
- the filtered polymer particles were suspended twice in methanol (400 mL) and the suspension was stirred for 40 minutes. This process was repeated.
- the polymer was suspended in 500 mL 2M NaCl solution and the suspension was stirred for 40 minutes. This NaCl treatment was repeated twice and the filtered polymer was suspended in 500 mL deionized water.
- the mixture was stirred for an additional 45 minutes, filtered, resuspended in 400 mL deionized water and stirred for another 40 minutes.
- 1 mL concentrated HCl was added and the mixture was stirred for 20 minutes.
- the polymer was filtered off and dried in a forced air oven at 60° C., yielding 13.2 g of alkylated polymer as a light yellow solid which was ground and passed through a 140 mesh sieve.
- Example 6 The 3% crosslinked poly(diallylmethylamine) of Example 6 (5 g) was taken in a 500 mL 3-necked round-bottomed flask and suspended in 110 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, a solution of 11.1 g 1-bromooctane in 50 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 1 g 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. for 1.5 hr. 1 g NaOH solution was added, and the reaction mixture was allowed to stir at 75° C. for an additional 18 hr.
- Example 6 The 3% crosslinked poly(diallylmethylamine) of Example 6 (5 g) was taken in a 500 mL 3-necked round bottomed flask and suspended in 100 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, 16 g 1-bromotetradecane dissolved in 40 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 1 g 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. for 1.5 hr. 1 g NaOH solution was then added and the reaction mixture was stirred at 75° C. for additional 18 hr.
- (3-Chloropropyl)dimethyloctadecylammonium bromide was prepared by the general method of Example 10 starting with dimethyloctadecylamine.
- a mixture of the crosslinked polymer gel of Example 6 and 35 g (3-chloropropyl)dimethyloctadecylammonium bromide was dispersed in 150 mL deionized water and the mixture was heated to 70° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH and 50 mL ethanol were then added to the reaction mixture. After 2 hr, 0.5 g NaOH solution was added and the reaction mixture was stirred at 70° C. for 20 hr.
- Example 7 The 3% crosslinked poly(diallylmethylamine) of Example 7 (5 g) and 30 g (3-chloropropyl)dodecyl-pyrrolidinium bromide were dispersed in 150 mL deionized water and the mixture was heated to 70° C. with stirring. After stirring at 70° C. for 15 minutes, 2 g 50% aqueous NaOH solution was added to the reaction mixture. After 2 hr, 1 g NaOH solution was added and the reaction mixture was allowed to stir at 70° C. for 20 hr. The reaction mixture was then allowed to cool to 30° C.
- N-decylpiperidine was synthesized by reacting 45.7 g piperidine with 118.7 g 1-bromodecane in 237 mL acetone in the presence of 74 g potassium carbonate. After refluxing this reaction mixture at 55° C. for 24 hr, it was filtered and acetone was removed from the filtrate to yield 61 g N-decylpiperidine. 5 g N-decylpiperidine and 42 g 1-bromo-3-chloropropane were dissolved in 50 mL methanol and the reaction mixture was heated at 65° C. for 18 hr. After cooling to room temperature, methanol was removed under reduced pressure.
- the polymer was filtered off and washed with 200 mL deionized water and 200 mL methanol.
- the polymer particles were dispersed in 500 mL methanol and the suspension was stirred for an additional 30 minutes, then filtered. This process was repeated once and the polymer was suspended in 300 mL 2M NaCl solution. The suspension was stirred for 45 minutes and filtered. After repeating this NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for 30 minutes, filtered, resuspended in 400 mL deionized water and the suspension was stirred for 40 minutes. To this polymer suspension was added 1 mL concentrated HCl and the mixture was stirred for 20 minutes. The polymer was filtered off and dried in a forced air oven at 60° C., yielding 13.2 g alkylated polymer as a pale white solid which was ground and passed through a 140 mesh sieve.
- Example 10 (4-Chlorobutyl)diethyldecylammonium bromide was prepared by the general method of Example 10 using 4-chloro-1-bromobutane and decyldiethylamine.
- the 3% crosslinked poly(diallylmethylamine) of Example 6 (5 g) and 22 g (4-chlorobutyl)diethyldecylammonium bromide were dispersed in 150 mL deionized water and the resulting mixture was heated to 70° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH was then added to the reaction mixture. After 2 hr, 0.5 g NaOH solution was added and the reaction mixture was allowed to stir at 70° C. for 20 hr.
- This example illustrates alkylation of the 3% crosslinked poly(diallylmethyl-amine) of Example 6 with different amounts of (3-chloropropyl)dimethyldodecyl-ammonium bromide.
- the polymer was treated with varying mole fractions of the alkylating agent (1.0, 0.75, 0.50, 0.25 and 0.10) via the general procedure described in Example 9.
- Table 2 summarizes amounts of (3-chloropropyl)dimethyldodecylammonium bromide used to obtain polymers of varying degree of alkylation and yield of alkylated polymer per gram of the 3% crosslinked poly(diallylmethylamine). This g/g yield is a measure of the degree of alkylation of the polymer.
- the suspension was stirred for 30 minutes and was filtered.
- the swollen polymer particles were resuspended in 400 mL D.I. water, stirred for 1 hr and filtered. This process was repeated twice more.
- the filtered polymer (swollen gel) was dried in a forced air oven at 60° C. to yield 15 g of the product.
- Example 33 5 g of the ground polymer (Example 33) was placed in a 500 mL 3-necked round-bottomed flask was suspended in 100 mL D.I. water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, 12 g 1-bromodecane dissolved in 100 mL ethanol was added and the reaction mixture stirred for 10 minutes. Subsequently, 1 g 50% aqueous sodium hydroxide was added and the reaction mixture was stirred at room temperature for 40 minutes followed by an additional 0.5 g of NaOH solution after another 1.5 hr (the base addition was such as to maintain the pH between 10 and 12). The reaction mixture was allowed to stir at 75° C.
- a solution of poly(diallylmethylamine)hydro-chloride (8.38 g of a 60% polymer solution in water), NaOH (5.5 g of a 50% NaOH solution in water), deionized water (150 mL) and (4-chlorobutyl)dimethyldodecyl ammonium bromide (26.2 g) was heated to 75° C. for 24 hours. After cooling to room temperature, the mixture was filtered. The solid was washed on the funnel with deionized water (1.5 L). The solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered.
- the solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was washed on the funnel with deionized water (2.0 L). The solid was suspended in deionized water (1.0 L), and concentrated HCl (1.4 mL) was added to this suspension. After stirring 1 hour, this suspension was filtered. The material was dried in a forced air oven at 60° C. for 24 hours to afford 19.1 g of product.
- the solid was washed on the funnel with deionized water (1.0 L).
- the solid was suspended in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered.
- the solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered.
- the solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered.
- the solid was washed on the funnel with deionized water (2.0 L).
- the solid was suspended in deionized water (1.0 L) and concentrated HCl (2.4 mL) was added to this suspension, and after stirring 1 hour, this suspension was filtered.
- the material was dried in a forced air oven at 60° C. for 24 hours to afford 20.8 g of product.
- a suspension of the product from Example 36 (5.01 g), methyl alcohol (100 mL), iodomethane (7.4 mL), and NaOH (1.0 g of a 50% NaOH solution in water) was stirred at room temperature for 24 hours. After the first 7 hours of reaction, iodomethane (7.4 mL) was added. After the 24 hour reaction period at room temperature, NaOH (1.0 g of a 50% NaOH solution in water) was added, and the mixture was heated to 50° C. for 4 hours. After one hour of heating, NaOH was added (1.0 g of a 50% NaOH solution in water). After the first 2.5 hours of heating (0.5 g of a 50% NaOH solution in water), NaOH was again added.
- a suspension of the product from Example 35 (5.01 g), methyl alcohol (100 mL), iodomethane (7.0 mL), and NaOH (1.0 g of a 50% NaOH solution in water) was stirred at room temperature for 24 hours. After 7 hours of reaction, iodomethane (7.0 mL) was added. Following a 24 hour reaction period at room temperature, NaOH (1.0 g of a 50% NaOH solution in water) was added, and the mixture was heated to 50° C. for 4 hours. After the first hour of heating, NaOH was added (1.0 g of a 50% NaOH solution in water). After 2.5 hours of heating, NaOH was again added (0.5 g of a 50% NaOH solution in water).
- the polymers produced in Examples 35-37 were tested in vivo, using the following protocol. After a week of acclimation to the facility, the animals were transferred to special cages that separate urine and feces. They were given only water for a 24 hour period in order to synchronize their urge for food as a drug. The food was presented for a 72 hour period. Fecal material was collected for 63 hours, from the hour 9 to hour 72 post presentation. The fecal material was freeze-dried to eliminate water from the material. It was pulverized with an amalgamator to a uniform powder, and 1 g was placed in the extraction cell. A solution of 80% methanol 100 mMol NaOH was used as the extraction solvent. The extraction was accelerated by holding the sample and solvent at 100° C. and 1500 psi for 5 minutes. The extraction was evaporated and reconstituted in bovine calf serum. The concentration was multiplied by four times the volume of extract and expressed as the concentration per gram of feces.
- This Example illustrates the role of the reaction temperature during alkylation of crosslinked of poly(diallylmethylamine) with 1-chlorodecane.
- the alkylation reactions were carried out at 70° C., 80° C., 90° and 100° C.
- the amount of 1-chlorodecane used and the reaction time was kept unchanged for all the reactions. Yield of the alkylated polymer thus obtained at these reactions temperatures are summarized in Table 4.
- This Example illustrates the role of the amounts of the 1-chlorodecane used in the alkylation of 4.5% epichlorohydrin crosslinked poly(diallylmethylamine) to prepare polymers with different degrees of alkylation.
- the polymer was treated with varying mole fractions of 1-chlorodecane (1.0, 0.5 and 0.25). All alkylation reactions were carried out at 90° C. for a period of 18 hr.
- Table 5 summarizes the amounts of 1-chlorodecane used to obtain polymers of varying degrees of alkylation and the yield of the corresponding alkylated polymers.
- Non-crosslinked Polydiallylamine hydrochloride (PDA-HCl) and non-crosslinked Poly(diallylmethylamine)hydrochloride (PDMA-HCl) were reacted with a variety of crosslinking agents and alkylating agents.
- the reactions conditions are analogous to those described in Example 42 where crosslinked poly(diallylmethylamine) was reacted with 1-chlorodecane.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Abstract
The present invention relates to a method for removing bile acids from a patient and certain polymers of use in the method. The method comprises the step of administering to the patient a therapeutically effective amount of a polymer composition which includes a a poly(diallylamine)polymer which is substituted with hydrophobic groups. The hydrophobic groups can be a substituted or unsubstituted, straight chain or branched C3-C24-alkyl group, an aralkyl group or an aryl group.
Description
- This application is a Continuation of U.S. application Ser. No. 10/647,665, filed Aug. 25, 2003, which is a Continuation of U.S. application Ser. No. 09/286,341, filed Apr. 5, 1999, which is a Continuation of International Application No. PCT/US97/23899, which designated the United States and was filed on Dec. 29, 1997, published in English and which is a Continuation-in-Part of U.S. Ser. No. 08/777,408, filed Dec. 30, 1996, now U.S. Pat. No. 6,203,785. The entire teachings of the above applications are incorporated herein by reference.
- Salts of bile acids act as detergents to solubilize and, consequently, aid in the digestion of, dietary fats. Bile acids are derived from cholesterol. Following digestion, bile acids can be passively absorbed in the jejunum or reabsorbed by active transport in the ileum. Bile acids which are not reabsorbed are deconjugated and dehydroxylated by bacterial action in the distal ileum and large intestine.
- Reabsorption of bile acids from the intestine conserves lipoprotein cholesterol in the bloodstream. Conversely, the blood cholesterol level can be reduced by hindering reabsorption of bile acids.
- One method of reducing the amount of bile acids that are reabsorbed is oral administration of compounds that sequester the bile acids and cannot themselves be absorbed. The sequestered bile acids consequently are excreted. Serum cholesterol is then employed to produce more bile acids, thereby lowering the serum cholesterol level of the patient.
- The present invention relates to a method for removing bile acids from a patient as well as certain polymers for use in the method. The method comprises the step of administering to the patient a therapeutically effective amount of a polymer characterized by a diallylamine monomer wherein the amino nitrogen atom bears at least one hydrophobic substituent. The hydrophobic substituent can be a substituted or unsubstituted, straight chain or branched C3-C24-alkyl group, a substituted or unsubstituted arylalkyl group or a substituted or unsubstituted aryl group. The polymer to be administered can be homopolymer or a copolymer.
- In one embodiment, the polymer to be administered is a crosslinked or linear poly(diallylamine)polymer wherein at least 10% of the amino nitrogen atoms are substituted by a C3-C24-alkyl group. In another embodiment, the polymer to be administered is characterized by a diallylamine monomer wherein the amino nitrogen atom bears an alkyl group which is substituted with a quaternary ammonium group. The nitrogen atom of the ammonium group can bear at least one terminal hydrophobic substituent.
- The polymer to be administered can comprise secondary amino groups, tertiary amino groups or quaternary ammonium groups or a combination thereof. Polymers which comprise secondary or tertiary amino groups can also be administered in the form of salts of a pharmaceutically acceptable acid.
- The polymer can be linear or crosslinked. In one embodiment, the polymer is crosslinked via the incorporation of a multifunctional comonomer. In another embodiment, the polymer is crosslinked via bridging groups which link amino nitrogen atoms on different polymer strands.
- In another embodiment, the invention relates to poly(diallylamine)polymers which are useful as bile acid sequestrants. These polymers are characterized by an diallylamine monomer, or repeat unit, wherein the amino nitrogen bears an alkyl substituent which is substituted with an ammonium group. The polymer can be a homopolymer or a copolymer.
- The present invention offers the advantage that both substituted and unsubstituted diallylamines are readily polymerized and crosslinked, in comparison to other amine monomers. Such polymers also provide improved efficacy over polymers utilized in prior art methods.
- The features and other details of the invention will now be more particularly described and pointed out in the claims. It will be understood that the particular embodiments of the invention are shown by way of illustration and not as limitations of the invention. The principal features of the invention can be employed in various embodiments without departing from the scope of the present invention.
- The present invention is based on Applicants' discovery that poly(diallylamine)polymers comprising hydrophobic groups exhibit excellent bile acid sequestration activity. The invention provides a method for removing bile acids from a patient comprising administering to the patient a therapeutically effective amount of a polymer characterized by a diallylamine monomer, or repeat unit, wherein the amino nitrogen atom bears a hydrophobic substituent.
- As used herein, the term “therapeutically effective amount” refers to an amount which is sufficient to remove a significant quantity of bile acids from the patient and, thus, to lower the serum cholesterol level of the patient. The patient can be an animal, for example, a mammal, or a human.
- A “hydrophobic substituent”, as the term is used herein, is a moiety which, as a separate entity, is more soluble in octanol than water. For example, the octyl (C8H17) group is hydrophobic because its parent alkane, octane, has greater solubility in octanol than in water. The hydrophobic substituent can be a saturated or unsaturated, substituted or unsubstituted hydrocarbon group. Such groups include susbstituted and unsubstituted, normal, branched or cyclic alkyl groups having 3 or more carbon atoms, substituted or unsubstituted arylalkyl or heteroarylalkyl groups and substituted or unsubstituted aryl or heteroaryl groups.
- In one embodiment, the polymer to be administered is a poly(diallylamine)polymer characterized by a diallylamine monomer wherein the amino nitrogen atom bears at least one hydrophobic substituent selected from the group consisting of substituted or unsubstituted, normal, branched or cyclic C3-C24-alkyl groups, such as a hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl or tetradecyl group; substituted or unsubstituted C3-C24-alkenyl groups, such as propenyl group; substituted or unsubstituted arylalkyl groups, such as a benzyl group; and substituted or unsubstituted aryl groups, such as a phenyl or naphthyl group. Suitable alkyl substituents include halo (e.g. fluoro, chloro, bromo or iodo) groups, and alkoxy, cycloalkyl, substituted and unsubstituted, quaternary, amido, sulfone, sulfoxide, alkoxy and aryl groups. Suitable aryl and arylalkyl substituents include fluoro, chloro, bromo, iodo, amino, ammonioalkyl, alkyl, alkoxy, hydroxy, alkoxy, sulfoxide and sulfone groups.
- In one embodiment, at least 10% of the amino nitrogen atoms within the polymer to be administered bear a hydrophobic substituent, such as a C2-C24-alkyl group. Preferably at least about 20% of the amino nitrogen atoms bear a hydrophobic substituent. In other embodiments, at least about 40% of the amino nitrogen atoms can bear a hydrophobic substituent.
- In general, poly(diallylamine)polymers are characterized by monomers, or repeat units, comprising five-membered rings, monomers comprising six-membered rings, or a combination thereof. In one embodiment, the polymer to be administered is characterized by an ammonium-bearing monomer of Formula I or of Formula II
or a combination thereof, wherein R1 is a hydrophobic substituent, as described above, and R2 is hydrogen, methyl, or a hydrophobic substituent. In a preferred embodiment, R1 is selected from among the octyl, decyl and dodecyl groups and R2 is methyl. - X− is an anion, such as the conjugate base of a pharmaceutically acceptable acid. Such anions include chloride, citrate, tartrate, lactate, phosphate, hydrophosphate, methanesulfonate, acetate, formate, maleate, fumarate, malate, succinate, malonate, sulfate, hydrosulfate, L-glutamate, L-aspartate, pyruvate, mucate, benzoate, glucuronate, oxalate, ascorbate and acetylglycinate. In a preferred embodiment, X− is chloride.
-
- In a preferred embodiment, the polymer to be administered comprises one or more monomers of Formulas I-IV wherein at least 10%, preferably at least about 20%, of the amino nitrogen atoms bear a C3-C24-alkyl substituent. Examples of particularly preferred C3-C24-alkyl groups include hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl and tetradecyl groups.
- The polymer to be administered can be a copolymer comprising one or more diallylamine monomers, such as one or more monomers of Formulas I, II, III, and IV, and at least one additional monomer. In one embodiment, the additional monomer is sulfur dioxide. In polymers comprising sulfur dioxide, the polymer backbone includes —SO2— units between pairs of diallylamine monomers.
- In a further embodiment, the invention provides a method for removing bile acids from a patient comprising the step of administering to the patient a therapeutically effective amount of a polymer characterized by a diallylamine repeat unit wherein the amino nitrogen atom bears an ammonioalkyl substituent. The invention also includes the ammonioalkyl-substituted polymers which are of use in this method.
- The term “ammonioalkyl”, as used herein, refers to an alkyl group which is substituted by a nitrogen atom bearing three additional substituents. Thus, the nitrogen atom is an ammonium nitrogen atom which bears an alkylene substituent, which links this atom to the diallylamine nitrogen atom, and three additional substituents selected from among hydrogen, alkyl and arylalkyl. An ammonioalkyl group will further include a negatively charged counter ion, such as a conjugate base of a pharmaceutically acceptable acid.
- The diallylamine repeat unit can be, for example, of Formula I, Formula II, Formula III, or Formula IV, wherein at least one of the nitrogen substituents is an ammonioalkyl substituent. Suitable ammonioalkyl substituents are of the general formula
wherein R4, R5 and R6 are each, independently, a hydrogen atom or a C1-C24 alkyl group; n is an integer from 2 to about 20, preferably from 3 to about 6; and X− is an anion, such as a conjugate base of a pharmaceutically acceptable acid. Preferably, at least one of R4, R5 and R6 is a hydrophobic group such as a C3-C24-alkyl group. More preferably, at least one of R4, R5 and R6 is a C6-C24-alkyl group. Suitable examples of ammonioalkyl groups include, but are not limited to, 4-(dioctylmethylammonio)butyl; 3-(dodecyldimethylammonio)propyl; 3-(octyldimethylammonio)propyl; 3-(decyldimethylammonio)propyl; 5-(dodecyldimethylammonio)pentyl; 3-(cyclohexyldimethylammonio)propyl; 3-(decyldimethylammonio)-2-hydroxypropyl; 3-(tridecylammonio)propyl; 3-(docosyldimethylammonio)propyl; 4-(dodecyldimethylammonio)butyl; 3-(octadecyldimethylammonio)propyl; 3-(hexyldimethylammonio)propyl; 3-(methyldioctylammonio)propyl; 3-(didecylmethylammonio)propyl; 3-(heptyldimethylammonio)propyl; 3-(dimethylnonylammonio)propyl; 6-(dimethylundecylammonio)hexyl; 4-(heptyldimethylammonio)butyl; 3-(dimethylundecylammonio)propyl; and 3-(tetradecyldimethylammonio)propyl. - The polymer can be a homopolymer which comprises only a monomer selected from among Formulas I-IV, above, wherein the nitrogen atom bears at least one ammonioalkyl substituent. The polymer can also be a copolymer which comprises a monomer of this type and at least one additional monomer. For example, the polymer can comprise a second diallylamine monomer wherein the nitrogen atom bears a substituent selected from among hydrogen, methyl, ethyl, hydrophobic groups and ammonioalkyl groups.
- The polymer can also comprise an additional monomer which is not a diallylamine. Suitable examples of additional polymers include substituted and unsubstituted acrylate, acrylamide, methacrylate, methacrylamide, allylamine, allyl alcohol, vinyl amine and vinyl alcohol. For example, the additional monomer can be a substituted acrylate or acrylamide which bears a hydrophobic group, such as a C3-C24-alkylacrylate or an N—C3-C24-alkylacrylamide. The additional monomer can also be a hydrophilic monomer, such as N-(2-hydroxyethyl)acrylamide or (3-hydroxypropyl)acrylate. Also included are the multifunctional crosslinking co-monomers which are discussed in detail below.
- The copolymers can have a wide range of compositions. Typically, the ammonioalkyl-substituted diallylamine monomer will constitute from about 10% to about 90% of the monomeric units composing the polymer.
- The polymers of use in the present method can be linear or crosslinked. The polymer can be crosslinked, for example, by the incorporation within the polymer of a multifunctional comonomer. Suitable multifunctional co-monomers include diacrylates, triacrylates and tetraacrylates, dimethacrylates, diacrylamides, diallylacrylamide and di(methacrylamides). Specific examples include ethylene glycol diacrylate, propylene glycol diacrylate, butylene glycol diacrylate, ethylene glycol dimethacrylate, butylene glycol dimethacrylate, methylene bis(methacrylamide), ethylene bis(acrylamide), ethylene bis(methacrylamide), ethylidene bis(acrylamide), ethylidene bis(methacrylamide), pentaerythritol tetraacrylate, trimethylolpropane triacrylate, bisphenol A dimethacrylate, and bisphenol A diacrylate. Other suitable multifunctional monomers include polyvinylarenes, such as divinylbenzene. The amount of crosslinking agent is typically between 1.0% and 25% by weight relative to the weight of the polymer, preferably from about 2.5% to about 20% by weight and more preferably from about 2% to about 12% by weight.
- The polymer can also be crosslinked by bridging units which link amino groups on adjacent polymer strands. Suitable bridging units include straight chain or branched, substituted or unsubstituted alkylene groups, diacylalkylene groups, diacylarene groups and alkylene bis(carbamoyl) groups. Examples of suitable bridging units include —(CH2)n—, wherein n is an integer from about 2 to about 20; —CH2—CH(OH)—CH2—; —C(O)CH2CH2C(O)—; —CH2—CH(OH)—O—(CH2)n—O—CH(OH)—CH2—, wherein n is 2 to about 4; —C(O)—(C6H2(COOH)2)—C(O)— and —C(O)NH(CH2)pNHC(O)—, wherein p is an integer from about 2 to about 20.
- Advantageously, crosslinking the polymers renders the polymers non-adsorbable and stable in the patient. A “stable” polymer composition, when administered in therapeutically effective amounts, does not dissolve or otherwise decompose to form potentially harmful byproducts, and remains substantially intact.
- Polymers of use in the present method are, preferably, of a molecular weight which enables them to reach and remain in the gastrointestinal tract for a sufficient period of time to bind a significant amount of one or more bile acids. The polymers should, thus, be of sufficiently high molecular weight to resist, partially or completely, absorption from the gastrointestinal tract into other regions of the body. The resulting polymer/bile salt complex should then be excreted from the body. Suitable linar (non-crosslinked) polymers have molecular weights which range from about 2,000 Daltons to about 500,000 Daltons, preferably from about 5,000 Daltons to about 150,000 Daltons. Crosslinked polymers, however, are not generally characterized by molecular weight. The crosslinked polymers discussed herein should be sufficiently crosslinked to resist adsorption from the gastrointestinal tract.
- The polymer network can be administered orally to a patient in a dosage of about 1 mg/kg/day to about 10 g/kg/day; the particular dosage will depend on the individual patient (e.g., the patient's weight and the extent of bile salt removal required). The polymer can be administered either in hydrated or dehydrated form, and can be flavored or added to a food or drink, if desired, to enhance patient acceptance. Additional ingredients such as other bile acid sequestrants, drugs for treating hypercholesterolemia, atherosclerosis or other related indications, or inert ingredients, such as artificial coloring agents, may be added as well.
- Examples of suitable forms for administration include pills, tablets, capsules, and powders (i.e. for sprinkling on food). The pill, tablet, capsule or powder can be coated with a substance capable of protecting the composition from the gastric acid in the patient's stomach for a period of time sufficient for the composition to pass undisintegrated into the patient's small intestine. The polymer can be administered alone or in combination with a pharmaceutically acceptable carrier, diluent or excipient substance, such as a solid, liquid or semi-solid material. Examples of suitable carriers, diluents and excipients include lactose, dextrose, sucrose, sorbitol, mannitol, starches, gum acacia, alginates, tragacanth, gelatin, calcium silicate, cellulose and others known in the art.
- Polymers of use in the present method can be prepared using techniques known in the art of polymer synthesis (see for example, Shalaby et al., ed., Water-Soluble Polymers, American Chemical Society, Washington D.C. (1991)). For example, the appropriate monomer can be polymerized by methods known in the art, for example, via a free radical addition process. In this case the polymerization mixture includes a free-radical initiator, such as a free radical initiator selected from among those which are well known in the art of polymer chemistry. Suitable free-radical initiators include azobis(isobutyronitrile), azobis(4-cyanovaleric acid), azobis(amidinopropane)dihydrochloride, potassium persulfate, ammonium persulfate and potassium hydrogen persulfate. The free radical initiator is preferably present in the reaction mixture in an amount ranging from about 0.1 mole percent to about 5 mole percent relative to the monomer.
- The polymer can be crosslinked, for example, by including a multifunctional co-monomer as the crosslinking agent in the reaction mixture. A multifunctional co-monomer can be incorporated into two or more growing polymer chains, thereby crosslinking the chains. Suitable multifunctional co-monomers include those discussed above. The amount of crosslinking agent added to the reaction mixture is, generally, between 1.0% and 25% by weight relative to the combined weight of the polymer and the crosslinking agent, and preferably from about 2.5% to about 20% by weight.
- The multifunctional co-monomer can also take the form of a multifunctional diallylamine, such as a bis(diallylamino)alkane or a bis(diallylalkylammonio)alkane. Suitable monomers of this type include 1,10-bis(diallylmethylammonio)decane dibromide and 1,6-bis(diallylmethylammonio)hexane, each of which can be formed by the reaction of diallylmethylamine with the appropriate dibromoalkane.
- The polymers to be administered can also be crosslinked subsequent to polymerization by reacting the polymer with one or more crosslinking agents having two or more functional groups, such as electrophilic groups, which react with amine groups to form a covalent bond. Crosslinking in this case can occur, for example, via nucleophilic attack of the polymer amino groups on the electrophilic groups. This results in the formation of a bridging unit which links two or more amino nitrogen atoms from different polymer strands. Suitable crosslinking agents of this type include compounds having two or more groups selected from among acyl chloride, epoxide, and alkyl-X, wherein X is a suitable leaving group, such as a halo, tosyl or mesyl group. Examples of such compounds include epichlorohydrin, succinyl dichloride, butanedioldiglycidyl ether, ethanedioldiglycidyl ether, pyromellitic dianhydride and dihaloalkanes. The crosslinking agent can also be an α,ω-alkylene diisocyanate, for example OCN(CH2)pNCO, wherein p is an integer from about 2 to about 20. The polymer can be reacted with an amount of crosslinking agent equal from about 0.5 and 20 mole percent relative to the amino groups within the polymer, depending upon the extent of crosslinking desired.
- A polymer comprising alkylated amino groups can be formed by reacting a preformed polymer with a suitable alkylating agent, or by polymerizing an alkylated monomer. Suitable alkylated monomers can be prepared by reacting diallylamine or a diallylamine derivative, such as diallylmethylamine, with an alkylating agent. As used herein, the term “alkylating agent” refers to a compound which reacts with an amino group to form a nitrogen-carbon bond, thereby adding an alkyl or alkyl derivative substituent to the nitrogen atom. Suitable alkylating agents are compounds comprising an alkyl group or alkyl derivative which is bonded to a leaving group, such as a halo, tosylate, mesylate or epoxy group. Examples of preferred alkylating agents include C1-C24-alkyl halides, for example, n-butyl halides, n-hexyl halides, n-decyl halides, and n-octadecyl halides; C2-C24-dihaloalkanes, for example, 1,10-dihalodecanes; C1-C24-hydroxyalkyl halides, for example, 11-halo-1-undecanols; C1-C24-arylalkyl halides, for example, benzyl halide; C2-C24-alkylepoxy ammonium salts, for example, glycidylpropyl-trimethylammonium salts; and C2-C24-epoxyalkylamides, for example, N-(2,3-epoxypropyl)butyramide or N-(2,3-epoxypropyl)hexanamide. Preferred alkylating agents include halodecane, and halododecane, where in each case “halo” represents a chloro, bromo or iodo substituent.
- Diallylamine polymers having amino groups which bear quaternary ammonium-substituted alkyl groups can be prepared using alkylating agents such as (X— alkyl)ammonium salts, wherein X represents a suitable leaving group, as described above. These compounds can be prepared by the reaction of an appropriate dihaloalkane, such as a bromochloroalkane, with a tertiary amine. Suitable alkylating agents of this type include the following:
- (4-bromobutyl)dioctylmethylammonium bromide;
- (3-bromopropyl)dodecyldimethylammonium bromide;
- (3-chloropropyl)dodecyldimethylammonium bromide);
- (3-bromopropyl)octyldimethylammonium bromide;
- (3-chloropropyl)octyldimethylammonium bromide;
- (3-iodobutyl)dioctylmethylammonium bromide;
- (2,3-epoxypropyl)decyldimethylammonium bromide;
- (3-chloropropyl)decyldimethylammonium bromide;
- (5-tosylpentyl)dodecyldimethylammonium bromide;
- (6-bromohexyl)octyldimethylammonium bromide;
- (12-bromododecyl)decyldimethylammonium bromide;
- (3-bromopropyl)tridecylammonium bromide;
- (3-bromopropyl)docosyldimethylammonium bromide;
- (6-bromohexyl)docosyldimethylammonium bromide;
- (4-chlorobutyl)dodecyldimethylammonium bromide;
- (3-chloropropyl)octadecyldimethylammonium bromide;
- (3-chloropropyl)hexyldimethylammonium bromide;
- (3-chloropropyl)methyldioctylammonium bromide;
- (3-chloropropyl)methyldidecylammonium bromide;
- (3-chloropropyl)cyclohexyldimethylammonium bromide;
- (3-bromopropyl)heptyldimethylammonium bromide;
- (3-bromopropyl)dimethylnonylammonium bromide;
- (6-bromohexyl)dimethylundecylammonium bromide;
- (4-chlorobutyl)heptyldimethylammonium bromide;
- (3-chloropropyl)dimethylundecylammonium bromide; and
- (3-chloropropyl)tetradecyldimethylammonium bromide.
- Each of the alkylating agents described above can also exist and be used as a salt in combination with an anion other than bromide. For example, these and similar alkylating agents can be prepared and used as salts with a wide range of anions, including chloride, iodide, acetate, p-toluenesulfonate and methanesulfonate.
- When the hydrophobic groups are added to the polymer by way of an alkylating agent as described above, the extent of alkylation can be determined by methods which are well known in the chemical arts. The increase in polymer mass due to alkylation provides one measure of the extent of alkylation. For example, in a reaction between poly(diallylmethylamine) and 1-bromodecane, a product/starting material mass ratio of about 3.0, 2.0 and 1.5 represent approximately 100%, 50% and 25% alkylation, respectively. The degree of alkylation can also be determined by elemental analysis of the product polymer. In this case, the carbon/nitrogen (C/N) mass ratio is a direct measure of the degree of alkylation. For example, the reaction of poly(diallyhnethylamine) with 1-bromodecane yields a product with a higher C/N mass ratio than that of the starting polymer. Product C/N mass ratios of about 6, 8.2, 10.6 and 14.6 represent, approximately, 0%, 25%, 50% and 100% alkylation, respectively.
- The invention will now be further and specifically described by the following examples.
- To a 2 L Morton flask was added diallylmethylamine (100 g), 1-bromododecane (249 g), and tetrahydrofuran (750 mL). The mixture was heated to 65° C. for 44 h, and then allowed to cool to room temperature. The solvent was removed by rotary vacuum evaporation to leave two layers. Diethylether (500 mL) was added and the mixture was stirred for 1 hr. The mixture was allowed to settle and the top layer was decanted and discarded. Additional diethylether (500 mL) was added. The mixture was stirred for 24 h, and the top layer was again decanted and discarded. The remaining oil was dried in a vacuum oven at 65° C. for 4 days to yield 67 g of product.
- To a 1 L Morton flask was added diallylmethylamine (86.1 g), 1,10-dibromodecane (112 g), and methanol (100 mL). The mixture was heated to 65° C. for 24 h, and then allowed to cool to room temperature. The solvent was removed by rotary vacuum evaporation. Diethylether (400 mL) was added and the mixture was stirred for 1 hr. The mixture was allowed to settle and the top layer was decanted and discarded. The remaining oil was dried by rotary vacuum evaporation to yield 215 g of product.
- To a 1 L Morton flask was added diallylmethylamine (74.6 g), 1,6-dibromohexane (77 g), and methanol (100 mL). The mixture was heated to 65° C. for 17 h, and then allowed to cool to room temperature. Diethylether (300 mL) was added and the mixture was stirred for 1 hr. The solid was collected by filtration and resuspended in diethylether (200 mL). The mixture was stirred for 1 hr, and the solid again collected by filtration. The solid was then dried in a vacuum oven at 50° C. for 3 days to yield 136 g of product.
- To a 250-mL, round bottom flask was added 1,10-bis(diallylmethylammonio)decane dibromide (20 g) and water (40 g). Azobisisobutyramidine dihydrochloride (0.5 mL of a 50% aqueous solution) was added and nitrogen was bubbled through the mixture for 1 hr. The mixture was then heated to 60° C. with stirring for 4 hr, at which time additional azobisisobutyramidine dihydrochloride (0.5 mL of a 50% aqueous solution) was added.
- After 18 hr the solution was allowed to cool to room temperature. The resulting gel was removed and ground in a blender with water (500 mL). The solid was collected by centrifugation and resuspended in methanol (500 mL). After stirring for 1 hr, the solid was collected by filtration and resuspended in aqueous NaCl (500 mL of 1.5 M solution). After again stirring for 1 hr, the solid was collected by filtration. The aqueous NaCl rinse was repeated twice more, and the solid was rinsed with water until the conductivity of the rinse reached 0.3 mS/cm. The solid was dried in a forced air at 60° C. to yield 10.0 g of product.
- To a 500-mL round bottom flask was added 1,10-bis(diallylmethylammonio)decane dibromide (21.1 g), diallylmethyldodecylammonium bromide (21.1 g), and water (52 g). Azobisisobutyramidine dihydrochloride (1 mL of a 50% aqueous solution) was added and nitrogen was bubbled through the mixture for 1 hr. The mixture was then heated to 60° C. with stirring for 18 hr. The resulting gel was allowed to cool to room temperature. The gel was removed and ground in a blender with water (250 mL). The solid was collected by filtration and resuspended in methanol (250 mL). The solid was collected by filtration and resuspended in methanol (250 mL). After stirring for 1 hr, the solid was collected by filtration and resuspended in aqueous NaCl (250 mL of 1.5 M solution). After again stirring for 1 hr, the solid was collected by filtration. The aqueous NaCl rinse was repeated twice more, and the solid was rinsed with water until the conductivity of the rinse reached 0.08 mS/cm. The solid was dried in a forced-air oven at 60° C. to yield 17.6 g of product.
- A crosslinked gel of N-methyl-N; N-diallylamine polymer was prepared by reacting the corresponding linear soluble polymer with epichlorohydrin. The starting material, poly(diallylmethylamine) was obtained in the form of its hydrochloride salt from Nitto Boseki Co. The polymer was obtained as a 60% aqueous solution (PAS-M-1, Lot #51017). The chemical process to obtain insoluble gels of this polymer involved partial neutralization of the amine hydrochloride polymer with a base followed by treatment with a predetermined amount of epichlorohydrin at room temperature. Experimental details to obtain a typical crosslinked gel of poly(diallylmethylamine hydrochloride) are given below.
- 83 g of the polymer solution was diluted with 170 mL deionized water. While stirring, 6.8 g NaOH was added to the polymer solution. The reaction mixture was allowed to stir until all NaOH had dissolved. When the temperature of the solution had dropped to below 30° C., epichlorohydrin (1.2 mL) was added and stirring continued. The reaction medium slowly became viscous and after about 80 minutes, had gelled and the stirring was stopped. The polymer gel was left at room temperature for an additional 60 hr. The polymer slab was broken into smaller pieces and dispersed in 400 mL deionized water. The resulting suspension was stirred for 2 hr and then filtered. The swollen polymer particles were resuspended in 600 mL deionized water, stirred for 45 minutes and collected by filtration. The process was repeated with 800 mL water and 1 hr stirring. After filtration, the filtrate showed a conductivity of 4 mS/cm. The filtered polymer (swollen gel) was dried in a forced air oven at 60° C. to yield 42 g of product.
- 25 g of the ground polymer (Example 6) taken in a 1 liter 3-necked round bottom flask was suspended in 250 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel was added 100 g 1-bromodecane dissolved in 250 mL ethanol and the reaction mixture was stirred for 10 minutes. Subsequently, 5 g of 50% aqueous sodium hydroxide was added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. for 1 hr. 2 g NaOH solution was then added followed by additional 2 g of NaOH solution after another 1.5 hr (the base addition was such as to maintain the pH between 10 and 12). The reaction mixture was stirred at 75° C. for an additional 18 hours, after which time heating was discontinued. After cooling to 30° C., 5 mL concentrated HCl was added and stirring was continued for 30 minutes. The pH of the medium dropped to 1.8. The polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. Polymer particles were suspended in 600 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL of 2 M NaCl solution and stirred for 40 minutes. The polymer was filtered and this process of NaCl treatment was repeated two more times. The filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes the polymer was filtered and resuspended in 700 mL deionized water and stirred for 30 minutes. Concentrated HCl (2 mL) was added to the suspension and the mixture was stirred for 15 minutes. The pH of the suspension was found to be 2.25. After stirring for an additional 20 minutes, the polymer was filtered and dried at 60° C. in a forced air oven, yielding 54.6 g of the alkylated polymer as a light yellow solid. The polymer was ground and passed through a 140 mesh sieve.
- 10 g of the ground polymer (Example 6) was suspended in 100 mL deionized water in a 500 mL 3-necked round-bottomed flask. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, 28 g 1-bromodecane dissolved in 100 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 2 g of 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes, followed by heating to 75° C. for 1 hr. 1 g NaOH solution was then added followed by an additional 1 g of NaOH solution after another 1.5 hr (the base addition was such as to maintain the pH between 10 and 12). The reaction mixture was stirred at 75° C. for an additional 18 h after which time the heating discontinued. After cooling to 30° C., concentrated HCl (2 mL) was added and the mixture was stirred for 30 minutes. The polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. Polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL 2M NaCl solution and stirred for 40 minutes. It was filtered and this process of NaCl treatment was repeated two more times. The filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes the polymer was filtered and resuspended in 500 mL deionized water and stirred for 30 minutes. Concentrated HCl (2 mL) was added to the suspension and the mixture was stirred for 15 minutes. The pH of the suspension was found to be 2.2. After stirring for an additional 20 minutes, the polymer was filtered and dried at 60° C. in a forced air oven, yielding 18 g of the alkylated polymer as a pale white solid. The polymer was ground and passed through a 140 mesh sieve.
- A two-liter, 3-necked, round-bottomed flask equipped with an air condenser and a magnetic stirring plate was charged with N,N-dimethyldodecylamine (297.24 grams, 1.40 moles), 1-bromo-3-chloropropane (220.44 grams, 1.40 moles) and methanol (250 mL). Reaction was maintained at 65° C. for 24 hours. Methanol was removed by rotary evaporation under reduced pressure to yield a brown sludge. To the sludge was added methyl-tert-butylether (2 liters) causing a white solid to form. The mixture was stirred for two hours and a semi-crystalline, white particulate was collected by vacuum filtration. The particulate was dried in a vacuum oven at 35° C. for 24 hours. Yield 228.2 grams (0.61 moles, 44%).
- (4-Chlorobutyl)dodecyldimethylammonium bromide and (6-chlorohexyl)dodecyldimethylammonium bromide can be prepared by a similar process using the appropriate bromochloroalkane and dodecyldimethylamine.
- A mixture of 11 g crosslinked polymer gel (Example 6) and 74 g (3-chloropropyl)-dimethyldodecylammonium bromide was dispersed in 250 mL deionized water and heated to 75° C. with stirring. After stirring at 75° C. for 15 minutes, 2 g of a 50% aqueous NaOH solution was added to the reaction mixture. After 2 hr, 1 g of NaOH solution was added followed by an additional 1 g after another 1 hr and the mixture was stirred at 75° C. for 23 hr. The reaction mixture was then allowed to cool. After cooling to 30° C., 3 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The polymer was filtered and washed with 200 mL methanol. The filtered polymer particles were dispersed in 400 mL methanol and stirred for 45 minutes and filtered. This process was repeated one more time, then the filtered polymer was suspended in 500 mL 2M NaCl solution, stirred for 45 minutes and filtered. This process of NaCl treatment was repeated twice and the filtered polymer was suspended in 500 mL deionized water. The mixture was stirred for 45 minutes, filtered, resuspended in 400 mL deionized water and stirred for an additional 40 minutes. To this suspension, 1 mL concentrated HCl was added and the mixture was stirred for 20 minutes. The polymer was filtered and dried in a forced air oven at 60° C., yielding 29 g of alkylated polymer as a light yellow solid which was ground and passed through a 140 mesh sieve.
- A mixture of 10 g 3% crosslinked polymer gel (Example 6) and 76 g (4-chlorobutyl)dimethyldodecyl-ammonium bromide was dispersed in 250 mL deionized water and heated to 70° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH was then added to the reaction mixture. After 2 hr, 1 g NaOH solution was added followed by additional 1 g after another 2 hr. The reaction mixture was then stirred at 70° C. for 20 hours. 1 g NaOH was then added and the reaction mixture was kept at 70° C. After 20 hr heating, 1 g NaOH solution was added and the reaction mixture was kept at 70° C. with stirring for 2 hr. After cooling to 30° C., 2 mL of concentrated HCl was added and the mixture was stirred for 20 minutes. The polymer was filtered and washed successively with 200 mL deionized water and 200 mL methanol. The filtered polymer particles were then dispersed in 500 mL methanol, stirred for 30 minutes, and filtered. This process was repeated an additional time and the filtered polymer was suspended in 400 mL 2M NaCl solution, stirred for 45 minutes and filtered. After repeating NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for 30 minutes, filtered, resuspended in 400 mL deionized water and stirred for an additional 40 minutes. To this polymer suspension, 1 mL concentrated. HCl was added and the mixture was stirred for 20 minutes. The polymer was then filtered and dried in a forced air oven at 60° C., yielding 27 g alkylated polymer as a light yellow solid which was ground and passed through a 140 mesh sieve.
- A mixture of 10 g 3% crosslinked polymer gel (Example 6) and 71 g (6-chlorohexyl)dimethyldodecyl-ammonium bromide was dispersed in 200 mL deionized water and heated to 75° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH was then added to the reaction mixture. After 3 hr, 1 g NaOH solution was added. After 2.5 hr an additional 1 g of NaOH solution was added and the reaction mixture was stirred at 75° C. for 22 hr. 0.5 g NaOH was then added and heating was continued for an additional 2 hr. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 15 minutes. The polymer was then filtered and washed successively with 200 mL deionized water and 200 mL methanol. The filtered polymer particles were then dispersed in 500 mL methanol, stirred for 30 minutes and filtered. This process was repeated two times, then the filtered polymer was suspended in 400 mL 2M NaCl solution, stirred for 45 minutes and filtered. After repeating the NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for 30 minutes, filtered, and resuspended in 400 mL deionized water and stirred for an additional 40 minutes. To this polymer suspension was added 1 mL concentrated HCl and the mixture was stirred for 20 minutes. The polymer was filtered and dried in a forced air oven at 60° C., yielding 25 g alkylated polymer as a white solid, which was ground and passed through a 140 mesh sieve.
- This example illustrates alkylation of the 4.5% crosslinked poly(diallylmethylamine) with different amounts of 1-bromodecane to obtain quaternized polyamines bearing varying amounts of hydrophobic groups. For this purpose, the polymer was treated with varying mole fractions of 1-bromodecane (1.0, 0.75, 0.50, 0.25 and 0.10). Table 1 summarizes amounts of 1-bromoalkane used to obtain polymers of varying degree of alkylation and the yield of alkylated polymer per gram of the 4.5% crosslinked poly(diallylmethylamine) (Example 2). This g/g yield is a measure of the degree of alkylation of the polymer.
- 10 g of the 4.5% crosslinked poly(diallylmethyl-amine) was suspended in 150 mL deionized water. While stirring, 2 g 50% aqueous NaOH solution was added to the polymer and the suspension was stirred for 15 minutes. At this time an ethanol solution of 1-bromodecane (2.5 mL ethanol/g 1-bromodecane) was added and the reaction mixture was heated to 75° C. with stirring. After 2 hr, 1 g NaOH was added, followed by an additional 1 g of NaOH after another 2 hr. The reaction mixture was stirred at 75° C. for 18 hours and was then allowed to cool. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 15 minutes. The polymer was filtered and washed with 200 mL deionized water and 200 mL methanol for 30 minutes and filtered. This process was repeated twice and the filtered polymer was suspended in 400 mL of 2M NaCl solution, stirred for 45 minutes and filtered. After repeating the NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for an additional 30 minutes, filtered, resuspended in 400 mL deionized water and stirred for an additional 40 minutes. To this polymer suspension was added 1 mL concentrated HCl and the mixture was stirred for 20 minutes. The polymer was filtered, dried in a forced air oven at 60° C., ground and passed through a 140 mesh sieve. Yield of the polymers for different amounts of the 1-bromodecane used are summarized in Table 1. The calculation of % alkylation assumed protonation of 50% of the amino nitrogen atoms.
TABLE 1 Results of the alkylation of 4.5% crosslinked poly(diallylmethylamine) with varying amounts of 1-bromodecane (C10H21Br) (“ratio” = ratio of 1-bromodecane to polymer amino groups (mole/mole)). C10H21Br product product/starting Polymer Used used yield polymer % (g) (g) Ratio (g) (g/g) alkylation 10.0 17.0 1.0 17 1.7 35 10.0 12.5 0.75 16.8 1.68 34 10.0 8.0 0.50 14.3 1.43 22 10.0 4.25 0.25 11.8 1.18 9 10.0 1.70 0.10 10.6 1.06 3 - 10 g of 4.5% crosslinked polydiallylmethylamine (Example 6) was suspended in 100 mL in a 500 mL 3-necked round-bottomed flask of deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, was added 32 g 1-bromotetradecane dissolved in 100 mL ethanol, and the reaction mixture was stirred for 10 minutes. 2 g 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. for 1 hr. 1 g NaOH solution was then added followed by an additional 1 g of NaOH solution after another 1.5 hr (the base addition was such as to maintain the pH between 10 to 12). The reaction mixture was stirred at 75° C. for an additional 18 hours after which time the heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. Polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL of 2M NaCl solution and stirred for an additional 40 minutes. The polymer was filtered and this process of NaCl treatment was repeated twice. The filtered polymer cake was then washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes the polymer was filtered and resuspended in 500 mL deionized water and the suspension was stirred for 30 minutes. 1 mL concentrated HCl was then added to the suspension, which was stirred for another 55 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 22 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- 10 g of 4.5% crosslinked poly(diallylmethylamine) (Example 7) was suspended in 100 mL in a 500 mL 3-necked round bottom flask of deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, was added 23 g 1-bromooctane dissolved in 100 mL ethanol and the reaction mixture was stirred for 10 minutes. 2 g of 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes, followed by heating to 75° C. for 1 hr. 1 g NaOH solution was then added, followed by an additional 1 g of NaOH solution after another 1.5 hr. The reaction mixture was allowed to stir at 75° C. for an additional 18 hours after which time the heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and stirring was continued for 30 minutes. The polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. Polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL 2M NaCl solution and the suspension was stirred for 40 minutes. The polymer was filtered and this process of NaCl treatment was repeated twice. The filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes the polymer was filtered, resuspended in 500 mL deionized water, and stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension and stirred for 35 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 15.8 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- 10 g of 4.5% crosslinked poly(diallylmethylamine) (Example 6) taken in a 500 mL 3-necked round bottom flask was suspended in 100 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel was added, 19 g 1-bromodecane dissolved in 100 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 2 g of 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes, followed by heating to 75° C. for 1 hr. 1 g NaOH solution was then added followed by an additional 1 g of NaOH solution after another 1.5 hr. The reaction mixture was stirred at 75° C. for an additional 18 hours after which time the heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The pH of the medium at this point was 2.0. The polymer was filtered and washed with 500 mL deionized water followed by 500 mL methanol. The polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL of 2 M NaCl solution and the suspension was stirred for 40 minutes. The polymer was filtered and this process of NaCl treatment was repeated twice. The filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes, the polymer was filtered, resuspended in 500 mL deionized water and stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension, which was stirred for 35 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 13.7 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- Diallylmethylamine (33.3 g) and 1-bromodecane (66.6 g) were dissolved in 100 mL methanol and the reaction mixture was stirred at 65° C. for 48 hours. After cooling to room temperature, the methanol was removed under reduced pressure. The residual viscous oil was precipitated into 800 mL dry ether with rapid stirring. The ether layer was decanted and the residue was again treated with 500 mL dry ether. After stirring for 15 minutes the solvent was removed and the oily residue was dried under vacuum at 35° C. for 48 hours, yielding 78 g of the product.
- A mixture of 22 g diallylmethylamine and 74 g 3-chloropropyldodecyldimethylammonium bromide were dissolved in 100 mL methanol and the reaction mixture was stirred at 65° C. for 48 hours. The progress of the reaction was monitored by the disappearance of the dialllymethylamine by thin layer chromatography (TLC). After cooling to room temperature, the solvent was removed under reduced pressure. The residual viscous oil was precipitated into 800 mL dry ether with rapid stirring. The ether layer was decanted and the residue was again treated with 500 mL dry ether. After stirring for 15 minutes the solvent was removed and the oily residue was dried under vacuum at 35° C. for 48 hours, yielding 70 g of the product.
- A mixture of 22 g diallylmethylamine and 75 g 4-chlorobutyldimethyldodecyl-ammonium bromide were dissolved in 100 mL methanol and the reaction mixture was stirred at 65° C. for 48 hours. The progress of the reaction was monitored by the disappearance of the diallylmethylamine by thin layer chromatography (TLC). After cooling to room temperature, the solvent was removed under reduced pressure. The residual viscous oil was precipitated into 800 mL dry ether with rapid stirring. The ether layer was decanted and the residue was again treated with 500 mL dry ether. After stirring for 15 minutes the solvent was removed and the oily residue was dried under vacuum at 35° C. for 48 hours, yielding 65 g of the product.
- 25 g N-decyldiallylmethylammonium bromide, 3 g N,N-methylenebis-acrylamide and 300 mg 2,2′-azobis(2-amidinopropane)dihydrochloride were dissolved in 100 mL deionized water. The solution was bubbled with a slow stream of nitrogen for 30 minutes then heated to 70° C. with stirring. After 2 hr, the reaction mixture turned cloudy with formation of a suspension. The mixture was kept at 70° C. for a period of 18 hours and then allowed to cool. The suspension was centrifuged. The residue dispersed in 200 mL deionized water, stirred for 30 minutes and centrifuged. After removal of the supernatant, the residue was suspended in 200 mL methanol, stirred for 30 minutes and centrifuged. The residue was suspended in 300 mL methanol and the suspension was refluxed for 1 hr. After cooling to room temperature, the suspension was filtered and the white solid was dried at 60° C. for 24 hr to yield 10 g of the polymer. The polymer was ground and passed through 140 mesh sieve.
- 111 g of a 20% solution of copoly(diallylmethyl-ammonium chloride-co-sulfur dioxide) (PAS-92, obtained from Nitto Boseki Co., Japan) was treated with 2.2 g solid NaOH with stirring. The solution turned cloudy and phase separation occurred. The bottom viscous layer was separated from the top layer and the former was diluted with 20 mL water. To this solution, 0.6 mL epichlorohydrin was added and the reaction mixture was allowed to stir for 2 hr. The reaction medium slowly became increasingly viscous and was left at room temperature for 48 hours, during which period it turned into a gel. The resulting polymer gel was broken into smaller pieces and was dispersed in 1 liter deionized water. The suspension was stirred for 1 hr and filtered. The swollen polymer particles were resuspended in 800 mL deionized water and stirred for 1.5 hr. The polymer particles were then filtered and dried in a forced air oven at 60° C. to yield 16 g of polymer. The dried polymer was ground and passed through a 10 mesh sieve.
- The polymer (5 g) of Example 20 was placed in a 500 mL 3-necked round bottom flask and suspended in 100 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, a solution of 18 g 1-bromodecane in 100 mL ethanol was added and the reaction mixture stirred for 10 minutes. Subsequently, 2 g 50% aqueous sodium hydroxide was added and the reaction mixture was stirred at room temperature for 30 minutes followed by heating to 75° C. After 1 hr, 0.5 g NaOH solution was added followed by an additional 0.5 g of NaOH solution after another 1.5 hr. The reaction mixture was allowed to stir at 75° C. for an additional 18 hr after which time the heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The pH of the medium dropped to 1.2. The polymer was filtered off and washed with 500 mL deionized water and 500 mL methanol. Polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 500 mL 2M NaCl solution and stirred for 40 minutes. The suspension was filtered and the NaCl treatment was repeated two more times. The filtered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring for 30 minutes it was filtered and resuspended in 500 mL deionized water and stirred for 30 minutes. 1 mL of concentrated HCl was added to the suspension and the suspension was stirred for 35 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 9.1 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- To a mixture of 5 g of the polymer of Example 20 and 30 g (3-chloropropyl)dimethyldodecylammonium bromide in a 500 mL 3-necked round bottom flask was added 150 mL deionized water. The resulting mixture was stirred with a mechanical stirrer. 2 g of 50% aqueous sodium hydroxide was added and the reaction mixture was stirred at room temperature for 30 minutes, followed by heating to 75° C. for 1 hr. NaOH solution (0.5 g) was added, followed by an additional 0.5 g of NaOH solution after another 1.5 hr. The reaction mixture was allowed to stir at 75° C. for an additional 18 hr after which time the heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The pH of the medium dropped to 2.8. The polymer was filtered off and washed with 500 mL deionized water and 500 mL methanol. Polymer particles were then suspended in 300 mL methanol and the suspension was stirred for 40 minutes. The polymer was isolated by filtration and then suspended in 500 mL 2M NaCl solution. The suspension was stirred for 40 minutes. The polymer was filtered off and this NaCl treatment was repeated two more times. The filtered polymer cake was washed with 500 mL deionized water and then suspended in 500 mL deionized water. After stirring for 30 minutes the polymer was filtered off and resuspended in 500 mL deionized water. The suspension was stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension and the suspension was stirred for 35 minutes. The polymer was then filtered and dried at 60° C. in a forced air oven, yielding 11.4 g of the alkylated polymer. The polymer was ground and passed through a 140 mesh sieve.
- 100 g diallylamine and 100 mL deionized water were placed in a 1 liter beaker and the mixture was allowed to stir. To this stirred mixture, 37% aqueous HCl was added slowly with concurrent measurement of pH. When the pH of the solution dropped below 7, addition of acid stopped. The solution was extracted with 600 mL diethyl ether. To the aqueous solution, 3 g 2,2′-azobis(2-amidinopropane)dihydrochloride was added and the solution was bubbled with nitrogen gas for 45 minutes. The solution was then heated to 70° C. for 48 hr, after which time the reaction mixture has turned viscous. Heating was discontinued and, after cooling to room temperature, 315 g of polymer solution was obtained.
- The polydiallylammonium chloride solution of Example 23 (150 g) was diluted with 50 mL deionized water. Solid NaOH (6.75 g) was added to the polymer solution with stirring. The reaction mixture was stirred until the NaOH has dissolved and temperature of the solution had dropped to below 30° C. To this partially neutralized polymer solution, epichlorohydrin (1.2 mL) was added and stirring was continued. The reaction medium slowly became increasingly viscous and after about 50 minutes it gelled and the stirring stopped. This gelled polymer was left at room temperature for an additional 48 hr to yield a semi-brittle polymer slab. The polymer slab was broken into smaller pieces and was dispersed in 1 L deionized water. The resulting suspension was stirred for 1.5 hr and then filtered. The swollen polymer particles were resuspended in 1 L deionized water and the suspension was stirred for 40 minutes. The polymer particles were filtered off and dried in a forced air oven at 60° C. to yield 56 g of pale white solid polymer. The dried polymer was ground and passed through a 10 mesh sieve.
- The ground polymer of Example 23 (5 g) was placed in a 500 mL 3-necked round-bottomed flask and suspended in 100 mL deionized water and the suspension was stirred with a mechanical stirrer. To this swollen gel, a solution of 15 g 1-bromodecane in 100 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 2 g 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. Subsequently, an additional 4 g 50% NaOH was added in a 1 g batch at an interval of 1.5 hr (the base addition maintained a pH between 10 to 12). The reaction mixture was allowed to stir at 75° C. for a total period of 20 hr. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The polymer was filtered off and washed with 500 mL deionized water and 500 mL methanol. The filtered polymer particles were slurried in methanol (400 mL), stirred for 40 minutes and reisolated by filtration. This process was then repeated. The polymer was suspended in 500 mL 2M NaCl solution and the suspension was stirred for 40 minutes. The polymer was filtered off and this NaCl treatment was repeated two more times. The fitered polymer cake was washed with 500 mL deionized water and suspended in 500 mL deionized water. After stirring the suspension for 30 minutes, the polymer was filtered off and resuspended in 500 mL deionized water. The resulting suspension was stirred for 30 minutes. 1 mL concentrated HCl was added to the suspension, which was then stirred for 35 minutes. The pH of the suspension was found to be 2.2. The polymer was then filtered off and dried at 60° C. in a forced air oven, yielding 13.3 g of the alkylated polymer as a pale white solid. The polymer was ground and passed through a 140 mesh sieve.
- A mixture of 5 g of the crosslinked polymer gel of Example 23 and 28 g (3-chloropropyl)dimethyl-dodecylammonium bromide was dispersed in 150 mL deionized water and the suspension was stirred. To this suspension 2 g 50% NaOH was added and the mixture was stirred for 15 minutes. The mixture was then heated with stirring to 75° C. An additional 4 g 50% NaOH was added in 1 g batches at 1.5 hr intervals (the base addition was such as to maintain the pH between 10 to 12). After stirring at 75° C. for a total period of 18 hr, the reaction mixture was allowed to cool. After cooling to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The polymer particles were filtered off and washed with 200 mL methanol. The filtered polymer particles were suspended twice in methanol (400 mL) and the suspension was stirred for 40 minutes. This process was repeated. After removing the polymer by filtration, the polymer was suspended in 500 mL 2M NaCl solution and the suspension was stirred for 40 minutes. This NaCl treatment was repeated twice and the filtered polymer was suspended in 500 mL deionized water. The mixture was stirred for an additional 45 minutes, filtered, resuspended in 400 mL deionized water and stirred for another 40 minutes. To this suspension, 1 mL concentrated HCl was added and the mixture was stirred for 20 minutes. The polymer was filtered off and dried in a forced air oven at 60° C., yielding 13.2 g of alkylated polymer as a light yellow solid which was ground and passed through a 140 mesh sieve.
- The 3% crosslinked poly(diallylmethylamine) of Example 6 (5 g) was taken in a 500 mL 3-necked round-bottomed flask and suspended in 110 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, a solution of 11.1 g 1-bromooctane in 50 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 1 g 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. for 1.5 hr. 1 g NaOH solution was added, and the reaction mixture was allowed to stir at 75° C. for an additional 18 hr. After the mixture had cooled to 30° C., 2.5 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The polymer was filtered and washed with 300 mL deionized water and 300 mL methanol. Polymer particles were suspended in 300 mL methanol and the suspension was stirred for 40 minutes. After removing the polymer by filtration, the polymer was suspended in 300 mL 2 M NaCl solution and the suspension was stirred for 40 minutes. The polymer was filtered off and this NaCl treatment was repeated two more times. The filtered polymer cake was washed with 400 mL deionized water, then suspended in 400 mL deionized water. After the suspension was stirred for 30 minutes, it was filtered and the polymer was resuspended in 400 mL deionized water and this suspension was stirred for an additional 30 minutes. 1 mL concentrated HCl was added to the suspension, which was then stirred for 30 minutes. The polymer was filtered and dried at 60° C. in a forced air oven, yielding 7.0 g of the alkylated polymer as a pale white solid. The polymer was ground and passed through a 140 mesh sieve.
- The 3% crosslinked poly(diallylmethylamine) of Example 6 (5 g) was taken in a 500 mL 3-necked round bottomed flask and suspended in 100 mL deionized water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, 16 g 1-bromotetradecane dissolved in 40 mL ethanol was added and the reaction mixture was stirred for 10 minutes. 1 g 50% aqueous sodium hydroxide was then added and the reaction mixture was stirred at room temperature for 40 minutes followed by heating to 75° C. for 1.5 hr. 1 g NaOH solution was then added and the reaction mixture was stirred at 75° C. for additional 18 hr. After cooling to 30° C., 2.5 mL concentrated HCl was added and the mixture was stirred for 30 minutes. The polymer was filtered and washed with 300 mL deionized water and 300 mL methanol. Polymer particles were suspended in 300 mL methanol and the suspension was stirred for 40 minutes. After removing the polymer by filtration, the polymer was suspended in 300 mL 2M NaCl solution and the suspension was stirred for 40 minutes. The polymer was filtered off and this NaCl treatment was repeated two more times. The filtered polymer cake was washed with 400 mL deionized water and suspended in 400 mL deionized water. After stirring for 30 minutes the suspension was filtered and the polymer was resuspended in 400 mL deionized water. This suspension was stirred for an additional 30 minutes. 1 mL concentrated HCl was then added to the suspension and stirring continued for 30 minutes. The polymer was filtered off and dried at 60° C. in a forced air oven, yielding 9.0 g of the alkylated polymer as a pale white solid. The polymer was ground and passed through a 140 mesh sieve.
- (3-Chloropropyl)dimethyloctadecylammonium bromide was prepared by the general method of Example 10 starting with dimethyloctadecylamine. A mixture of the crosslinked polymer gel of Example 6 and 35 g (3-chloropropyl)dimethyloctadecylammonium bromide was dispersed in 150 mL deionized water and the mixture was heated to 70° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH and 50 mL ethanol were then added to the reaction mixture. After 2 hr, 0.5 g NaOH solution was added and the reaction mixture was stirred at 70° C. for 20 hr. When the reaction mixture had cooled to 30° C., 2mL concentrated HCl was added and the mixture was stirred for another 20 minutes. The polymer was filtered off and washed with 200 mL deionized water and 200 mL methanol. The filtered polymer particles were dispersed in 500 mL methanol, stirred for another 30 minutes and then filtered. This process was repeated one more time and the filtered polymer was suspended in 300 mL 2M NaCl solution. The resulting suspension was stirred for another 45 minutes and filtered. After repeating the NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for 30 minutes, filtered, and the polymer was resuspended in 400 mL deionized water. The suspension was stirred for an additional 40 minutes. To this suspension was added 1 mL concentrated HCl and the mixture was stirred for 20 minutes. The polymer was filtered and dried in a forced air oven at 60° C., yielding 10.7 g alkylated polymer as a pale white solid which was ground and passed through a 140 mesh sieve.
- 47 g pyrrolidine, 149.5 g 1-bromododecane and 83 g potassium carbonate were added to 560 mL acetone. The reaction mixture was heated at 55° C. for 24 hr, then filtered. Solvent was removed from the filtrate, yielding 92 g N-dodecylpyrrolidine. 80 g N-dodecylpyrrolidine and 52.6 g 1-bromo-3-chloropropane were dissolved in 133 mL methanol and the reaction mixture was heated at 65° C. for 18 hr. After cooling to room temperature, methanol was removed under reduced pressure. The residue was poured into 2 L diethylether with stirring and the mixture was allowed to stand for another 6 hr. The white precipitate thus formed was filtered and was dried at 40° C. under a vacuum for 24 hr yielding 85 g (3-chloropropyl)dodecylpyrrolidinium bromide as a white solid.
- The 3% crosslinked poly(diallylmethylamine) of Example 7 (5 g) and 30 g (3-chloropropyl)dodecyl-pyrrolidinium bromide were dispersed in 150 mL deionized water and the mixture was heated to 70° C. with stirring. After stirring at 70° C. for 15 minutes, 2 g 50% aqueous NaOH solution was added to the reaction mixture. After 2 hr, 1 g NaOH solution was added and the reaction mixture was allowed to stir at 70° C. for 20 hr. The reaction mixture was then allowed to cool to 30° C.
- 2 mL concentrated HCl was then added and the mixture was stirred for 20 minutes. The polymer was filtered off and washed with 200 mL deionized water and 200 mL methanol. The polymer particles were dispersed in 500 mL methanol and the suspension was stirred for 30 minutes and then filtered. This process was repeated one more time and the filtered polymer was suspended in 300 mL 2M NaCl solution. The resulting suspension was stirred for 45 minutes and filtered. After repeating this NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for 30 minutes, filtered, resuspended in 400 mL deionized water and stirred for an additional 40 minutes. To this polymer suspension was added 1 mL concentrated HCl and stirring continued for an additional 20 minutes. The polymer was filtered off and dried in a forced air oven at 60° C., yielding 13 g alkylated polymer as a pale white solid which was ground and passed through a 140 mesh sieve.
- N-decylpiperidine was synthesized by reacting 45.7 g piperidine with 118.7 g 1-bromodecane in 237 mL acetone in the presence of 74 g potassium carbonate. After refluxing this reaction mixture at 55° C. for 24 hr, it was filtered and acetone was removed from the filtrate to yield 61 g N-decylpiperidine. 5 g N-decylpiperidine and 42 g 1-bromo-3-chloropropane were dissolved in 50 mL methanol and the reaction mixture was heated at 65° C. for 18 hr. After cooling to room temperature, methanol was removed under reduced pressure. The residue was poured into 2 L tert.butylmethyl ether with stirring and then the mixture was allowed to stand for 6 hr. The white precipitate thus formed was filtered and was dried at 40° C. under vacuum for 24 hr yielding 68 g (3-chloropropyl)decylpiperidinium bromide as a light yellow solid.
- The 3% crosslinked poly(diallylmethylamine) of Example 6 (5 g) and 32 g (3-chloropropyl)decylpiperidiniumammonium bromide were dispersed in 150 mL deionized water and the reaction mixture was heated to 70° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH was then added to the reaction mixture. After 2 hr, 1 g NaOH solution was added and the reaction mixture was allowed to stir at 70° C. for 20 hr. When the reaction mixture had cooled to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for 20 minutes. The polymer was filtered off and washed with 200 mL deionized water and 200 mL methanol. The polymer particles were dispersed in 500 mL methanol and the suspension was stirred for an additional 30 minutes, then filtered. This process was repeated once and the polymer was suspended in 300 mL 2M NaCl solution. The suspension was stirred for 45 minutes and filtered. After repeating this NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water. The mixture was stirred for 30 minutes, filtered, resuspended in 400 mL deionized water and the suspension was stirred for 40 minutes. To this polymer suspension was added 1 mL concentrated HCl and the mixture was stirred for 20 minutes. The polymer was filtered off and dried in a forced air oven at 60° C., yielding 13.2 g alkylated polymer as a pale white solid which was ground and passed through a 140 mesh sieve.
- (4-Chlorobutyl)diethyldecylammonium bromide was prepared by the general method of Example 10 using 4-chloro-1-bromobutane and decyldiethylamine. The 3% crosslinked poly(diallylmethylamine) of Example 6 (5 g) and 22 g (4-chlorobutyl)diethyldecylammonium bromide were dispersed in 150 mL deionized water and the resulting mixture was heated to 70° C. with stirring for 15 minutes. 2 g 50% aqueous solution of NaOH was then added to the reaction mixture. After 2 hr, 0.5 g NaOH solution was added and the reaction mixture was allowed to stir at 70° C. for 20 hr. When the reaction mixture had cooled to 30° C., 2 mL concentrated HCl was added and the mixture was stirred for an additional 20 minutes. The polymer was filtered off and washed with 200 mL deionized water and 200 mL methanol. The polymer particles were dispersed in 500 mL methanol and the suspension was stirred for 30 minutes and then filtered. This process was repeated once and the filtered polymer was suspended in 300 mL 2M NaCl solution. The suspension was stirred for an additional 45 minutes and filtered. After repeating this NaCl treatment twice, the filtered polymer was suspended in 400 mL deionized water and the mixture was stirred for an additional 40 minutes. To this polymer suspension was added 1 mL concentrated HCl and the mixture was stirred for 20 minutes. The polymer was filtered off and dried in a forced air oven at 60° C., yielding 10.6 g alkylated polymer as a pale white solid which was ground and passed through a 140 mesh sieve.
- This example illustrates alkylation of the 3% crosslinked poly(diallylmethyl-amine) of Example 6 with different amounts of (3-chloropropyl)dimethyldodecyl-ammonium bromide. For this purpose, the polymer was treated with varying mole fractions of the alkylating agent (1.0, 0.75, 0.50, 0.25 and 0.10) via the general procedure described in Example 9. Table 2 summarizes amounts of (3-chloropropyl)dimethyldodecylammonium bromide used to obtain polymers of varying degree of alkylation and yield of alkylated polymer per gram of the 3% crosslinked poly(diallylmethylamine). This g/g yield is a measure of the degree of alkylation of the polymer.
TABLE 2 Results of the alkylation of 3% crosslinked poly(diallylmethylamine) with varying amounts of (3-chloropropyl)dimethyldodecylammonium bromide (C12QC3C1Br). Polymer used Alkylating Mole frctn of Yield of Yield (g) agent used (g) alkylating agent alkylated (g/g) 5.0 14.25 1.0 11.3 2.3 5.0 10.7 0.75 8.3 1.7 5.0 7.1 0.50 7.0 1.40 5.0 3.6 0.25 6 1.20 5.0 1.40 0.10 5.1 1.02 - 33.2 g the 60% solution of poly(diallylmethylamine) (PAS-M-1, Lot #51017) was diluted with 68 mL D.I. water. While stirring, 2.8 g NaOH was added to the polymer solution. The reaction mixture was allowed to stir until all NaOH had dissolved. When the temperature of the solution has dropped to below 30° C., 1.25 g 1,4-butanediol diglycidyl ether was added and stirring continued. The reaction medium slowly became increasingly viscous and after about 45 minutes it gelled and the stirring was stopped. The polymer gel was left at room temperature for an additional 48 hours. The polymer slab was broken into smaller pieces and was dispersed in 300 mL D.I. water. The suspension was stirred for 30 minutes and was filtered. The swollen polymer particles were resuspended in 400 mL D.I. water, stirred for 1 hr and filtered. This process was repeated twice more. The filtered polymer (swollen gel) was dried in a forced air oven at 60° C. to yield 15 g of the product.
- 5 g of the ground polymer (Example 33) was placed in a 500 mL 3-necked round-bottomed flask was suspended in 100 mL D.I. water. The polymer swelled significantly and was stirred with a mechanical stirrer. To this swollen gel, 12 g 1-bromodecane dissolved in 100 mL ethanol was added and the reaction mixture stirred for 10 minutes. Subsequently, 1 g 50% aqueous sodium hydroxide was added and the reaction mixture was stirred at room temperature for 40 minutes followed by an additional 0.5 g of NaOH solution after another 1.5 hr (the base addition was such as to maintain the pH between 10 and 12). The reaction mixture was allowed to stir at 75° C. for an additional 18 hrs after which time heating was discontinued. After cooling to 30° C., 2 mL concentrated HCl was added and stirring for 30 minutes continued. The pH of the suspension dropped to 1.8. The polymer was filtered and washed with 250 mL D.I. water followed by 250 mL methanol. Polymer particles were suspended in 300 mL methanol and stirred for 40 minutes. After removing the solvent by filtration, the polymer was suspended in 250 mL 2M NaCl solution and stirred for an additional 40 minutes. It was filtered and this process of NaCl treatment was repeated two more times. The filtered polymer cake was washed with 250 mL D.I. water and suspended in 250 mL D.I. water. After stirring for 30 minutes it was filtered and resuspended in 400 mL D.I. water and stirred for an additional 30 minutes. 2 mL conc. HCl was added to the suspension and stirred for another 15 minutes. The pH of the suspension was found to be 2.10. After stirring for an additional 20 minutes, the polymer was filtered and dried at 60° C. in a forced air oven yielding 9 g of the alkylated polymer as a pale white solid. The polymer was ground and passed through a 140 mesh sieve.
- A solution of poly(diallylmethylamine)hydro-chloride (8.38 g of a 60% polymer solution in water), NaOH (5.5 g of a 50% NaOH solution in water), deionized water (150 mL) and (4-chlorobutyl)dimethyldodecyl ammonium bromide (26.2 g) was heated to 75° C. for 24 hours. After cooling to room temperature, the mixture was filtered. The solid was washed on the funnel with deionized water (1.5 L). The solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was washed on the funnel with deionized water (2.0 L). The solid was suspended in deionized water (1.0 L), and concentrated HCl (1.4 mL) was added to this suspension. After stirring 1 hour, this suspension was filtered. The material was dried in a forced air oven at 60° C. for 24 hours to afford 19.1 g of product.
- To a solution of poly(diallylmethylamine)hydro-chloride (16.7 g of a 60% polymer solution in water), NaOH (5.5 g of a 50% NaOH solution in water), deionized water (100 mL), and ethyl alcohol (100 mL) was added 1-bromodecane (44.4 g). This solution was then heated to 75° C. for 24 hours. After the first 2 hours of heating, NaOH (1.0 g of a 50% NaOH solution in water) was added. After cooling to room temperature, the mixture was evaporated on a rotary evaporator to remove the ethyl alcohol. Water (500 mL) was added to the mixture, and the mixture was filtered. The solid was washed on the funnel with deionized water (1.0 L). The solid was suspended in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2 M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was washed on the funnel with deionized water (2.0 L). The solid was suspended in deionized water (1.0 L) and concentrated HCl (2.4 mL) was added to this suspension, and after stirring 1 hour, this suspension was filtered. The material was dried in a forced air oven at 60° C. for 24 hours to afford 20.8 g of product.
- A suspension of the product from Example 36 (5.01 g), methyl alcohol (100 mL), iodomethane (7.4 mL), and NaOH (1.0 g of a 50% NaOH solution in water) was stirred at room temperature for 24 hours. After the first 7 hours of reaction, iodomethane (7.4 mL) was added. After the 24 hour reaction period at room temperature, NaOH (1.0 g of a 50% NaOH solution in water) was added, and the mixture was heated to 50° C. for 4 hours. After one hour of heating, NaOH was added (1.0 g of a 50% NaOH solution in water). After the first 2.5 hours of heating (0.5 g of a 50% NaOH solution in water), NaOH was again added. After cooling to room temperature, methyl alcohol (100 mL) was added to the mixture, and the mixture was evaporated on a rotary evaporator to remove the methyl alcohol. The solid was suspended in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was washed on the funnel with deionized water (4.0 L). The solid was suspended in deionized water (1.0 L) and concentrated HCl (50 drops) was added to this suspension, and after stirring 30 minutes, this suspension was filtered. The material was dried in a forced air oven at 60° C. to afford 5.2 g of product.
- A suspension of the product from Example 35 (5.01 g), methyl alcohol (100 mL), iodomethane (7.0 mL), and NaOH (1.0 g of a 50% NaOH solution in water) was stirred at room temperature for 24 hours. After 7 hours of reaction, iodomethane (7.0 mL) was added. Following a 24 hour reaction period at room temperature, NaOH (1.0 g of a 50% NaOH solution in water) was added, and the mixture was heated to 50° C. for 4 hours. After the first hour of heating, NaOH was added (1.0 g of a 50% NaOH solution in water). After 2.5 hours of heating, NaOH was again added (0.5 g of a 50% NaOH solution in water). After cooling to room temperature, methyl alcohol (100 mL) was added to the mixture, and the mixture was evaporated on a rotary evaporator to remove the methyl alcohol. The solid was suspended in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was suspended again in 2M NaCl (1.0 L), stirred for 30 minutes, and then filtered. The solid was washed on the funnel with deionized water (4.0 L). The solid was suspended in deionized water (1.0 L), and concentrated HCl (50 drops) was added to this suspension. After stirring 30 minutes, this suspension was filtered. The material was dried in a forced air oven at 60° C. to afford 4.9 g of product.
- The polymers produced in Examples 35-37 were tested in vivo, using the following protocol. After a week of acclimation to the facility, the animals were transferred to special cages that separate urine and feces. They were given only water for a 24 hour period in order to synchronize their urge for food as a drug. The food was presented for a 72 hour period. Fecal material was collected for 63 hours, from the hour 9 to hour 72 post presentation. The fecal material was freeze-dried to eliminate water from the material. It was pulverized with an amalgamator to a uniform powder, and 1 g was placed in the extraction cell. A solution of 80% methanol 100 mMol NaOH was used as the extraction solvent. The extraction was accelerated by holding the sample and solvent at 100° C. and 1500 psi for 5 minutes. The extraction was evaporated and reconstituted in bovine calf serum. The concentration was multiplied by four times the volume of extract and expressed as the concentration per gram of feces.
- It is clear from the results shown in Table 3 that these sequestrants are highly active in vivo, with efficacy far surpassing the commercial bile acid sequestrant cholestyramine.
TABLE 3 In Vivo Efficacy of Polymers of Examples 35-37 Bile Acid Excretion Polymer Dose (Percent in Diet) (μmole/g feces above control) None 0% 0 Cholestyramine 0.3% 1.7 0.60% 4.8 0.90% 6.3 1.20% 7.5 Example 35 0.10% 1.40 Example 36 0.10% 3.7 Example 37 0.10% 2.5 - In a 5 mL three necked round bottom flask was taken 10 g of the crosslinked poly(diallylmethylamine) of Example 6. To this was added 200 mL of deionized water. While stirring, 2 g of 50% aqueous NaOH solution was added to this polymer suspension. After stirring for 15 minutes, 13.6 g of 1-chlorodecane was added and the reaction mixture was heated to 90° C. with stirring. After 1.5 hr of heating, 1.0 g of reagant of the NaOH solution was added to the reaction mixture followed by an additional 0.5 g of the NaOH after another 2 hr. After stirring at 90° C. for a total period of 18 hr, the reaction mixture was allowed to cool to room temperature. Concentrated HCl (5 mL) was added to the reaction mixture and stirred for 30 minutes. The polymer was filtered and was washed with 500 mL of methanol. The polymer particles were suspended in 1 L of methanol, stirred for 30 minutes and filtered. After repeating this methanol washing once more, the polymer particles were suspended in 1 L of deionized water. The suspension was stirred for 30 minutes and filtered. The polymer particles were resuspended in 1 L of deionized water and stirred for 15 minutes. To this suspension was added 3 mL of concentrated HCl and the stirring continued for an additional 30 minutes. The particles were filtered and dried in a forced air oven at 60° C., yielding 16 g of the alkylated polymer as light yellowish solid. The polymer was ground and passed through a 140 mesh sieve.
- This Example illustrates the role of the reaction temperature during alkylation of crosslinked of poly(diallylmethylamine) with 1-chlorodecane. For this purpose, the alkylation reactions were carried out at 70° C., 80° C., 90° and 100° C. The amount of 1-chlorodecane used and the reaction time was kept unchanged for all the reactions. Yield of the alkylated polymer thus obtained at these reactions temperatures are summarized in Table 4.
- In a 500 mL three necked round bottomed flask was taken 10 g of the crosslinked poly(diallylmethylamine) (Example 6). To this was added 200 mL of deionized water. While stirring, 2 g of 50% aqueous NaOH solution was added to this polymer suspension. After stirring for 15 minutes, 13.6 g of 1-chlorodecane was added and the reaction mixture heated to the appropriate temperature with stirring. After 1.5 hr of heating, 1.0 g of reagent of the NaOH solution was added to the reaction mixture followed by an additional 0.5 g of the NaOH after another 2 hr. After stirring at the appropriate temperature for a total period of 18 hr, the reaction mixture was allowed to cool to room temperature. Concentrated HCl (5 mL) was added to the reaction mixture and stirred for 30 minutes. The polymer was filtered and was washed with 500 mL of methanol. The polymer particles were suspended in 1 L of methanol, stirred for 30 minutes and filtered. After repeating this methanol washing once more, the polymer particles were suspended in 1 L of deionized water. The suspension was stirred for 30 minutes and filtered. The polymer particles were resuspended in 1 L of deionized water and stirred for 15 minutes. To this suspension was added 3 mL of concentrated HCl and the stirring continued for an additional 30 minutes. The particles were filtered and dried in a forced air oven at 60° C. Yield of the alkylated polymers obtained at different reaction temperatures are summarized in Table 4. All the polymers were ground and passed through a 140 mesh sieve.
TABLE 4 Results on the role of the reaction temperature on the alkylation of 4.5% epichlorohydrin crosslinked poly(diallylmethylamine with 1-chlorodecane. Reaction Polymer used 1-Chlorodecance used Temperature Product Yield (g) (g) (° C.) (g) 10 13.6 70 11.6 10 13.6 80 13.5 10 13.6 90 16.0 10 13.6 100 17.0 - This Example illustrates the role of the amounts of the 1-chlorodecane used in the alkylation of 4.5% epichlorohydrin crosslinked poly(diallylmethylamine) to prepare polymers with different degrees of alkylation. For this purpose, the polymer was treated with varying mole fractions of 1-chlorodecane (1.0, 0.5 and 0.25). All alkylation reactions were carried out at 90° C. for a period of 18 hr. Table 5 summarizes the amounts of 1-chlorodecane used to obtain polymers of varying degrees of alkylation and the yield of the corresponding alkylated polymers.
- In a 500 mL three necked round bottomed flask was taken 10 g of the crosslinked poly(diallylmethylamine) (example 6). To this was added 200 mL of deionized water. While stirring, 2 g of 50% aqueous NaOH solution was added to this polymer suspension. After stirring for 15 minutes, appropriate amount of 1-chlorodecane was added and the reaction mixture heated to 90° C. with stirring. After 1.5 hr of heating, 1.0 g of reagent of the NaOH solution was added to the reaction mixture followed by an additional 0.5 g of the NaOH after another 2 hr. After stirring at 90° C. for a total period of 18 hr, the reaction mixture was allowed to cool to room temperature. Concentrated HCl (5 mL) was added to the reaction mixture and stirred for 30 minutes. The polymer was filtered and was washed with 500 mL of methanol. The polymer particles were suspended in 1 L of methanol, stirred for 30 minutes and filtered. After repeating this methanol washing once more, the polymer particles were suspended in 1 L of deionized water. The suspension was stirred for 30 minutes and filtered. The polymer particles were resuspended in 1 L of deionized water and stirred for 15 minutes. To this suspension was stirred for 30 minutes. The particles were filtered and dried in a forced air oven at 60° C. Yield of the alkylated polymers obtained for different alkylation levels are summarized in Table 5. All the polymers were ground and passed through a 140 mesh sieve.
TABLE 5 Results of the alkylation of 4.5% epichlorohydrin crosslinked polydiallymethyl-amine with varying amounts of 1-chlorodecane. Reaction Polymer used 1-Chlorodecane used Temperature Product Yield (g) (g) (° C.) (g) 10 3.4 90 12.2 10 6.8 90 14.5 10 10.2 90 15.7 10 13.6 90 16.0 - Non-crosslinked Polydiallylamine hydrochloride (PDA-HCl) and non-crosslinked Poly(diallylmethylamine)hydrochloride (PDMA-HCl) were reacted with a variety of crosslinking agents and alkylating agents. Table 6 gives details of the crosslinking and alkylating agents, reaction conditions and yields (IPA=isopropyl alcohol; PDA=poly(diallylamine), PDMA=poly(diallylmethylamine)). The reactions conditions are analogous to those described in Example 42 where crosslinked poly(diallylmethylamine) was reacted with 1-chlorodecane.
TABLE 6 Solvent Time Example Reactants (amount) (amount) Temperature (hr) Yield 43 PDMA.HCl (100.0 g of 60% ag H2O 75° C. 18 88 soln), 1-bromodecane (62.9 g), (600) mL epichlorohydrin (4.77 mL), NaOH (32.5 g of 50% aq soln) 44 PDMA.HCl (100.0 g of 60% aq IPA 75° C. 18 99 soln), 1-bromodecane (62.9 g), (100 mL) 1,6-dibromohexane (9.37 mL), H2O NaOH (5 addns of 6.5 g of 50% aq (500 mL) soln) 45 PDMA.HCl (100.0 g of 60% aq IPA 75° C. 18 92 soln), 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (4.77 mL), NaOH H2O (32.5 g of 50% ag soln) (500 mL) 46 PDA.HCl (103.7 g of 52.3% aq IPA 75° C. 18 53 soln), 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (4.77 mL), NaOH (7 H2O addns for a total of45 g of 50% aq (100 mL) soln) 47 PDA.HCl (103.7 g of 52.3% aq IPA 75° C. 18 67 soln), 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (4.77 mL), NaOH (90 g of 50% aq soln) 48 PDA.HCl (103.7 g of 52.3% aq IPA 75° C. 18 62 soln), 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (4.77 mL), NaOH (4 addns of 13.8 g of 50% aq soln) 49 PDA.HCl (103.7 g of 52.3% aq WA 75° C. 18 64 soln), 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (4.77 mL), NaOH H2O (135.0 g of 50% ag soln) (100 mL) 50 PDA.HCl (92.0 g of 59% aq soln), IPA 75° C. 18 90 1-bromodecane (62.9 g), 1,6- (100 mL) dibromohexane (9.37 mL), NaOH H2O (90.0 g of 50% aq soln) (100 mL) 51 PDA.HCl (95.3 g of 57% aq soln), IPA 75° C. 18 52 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (4.77 mL), HaOH H2O (90 g of 50% aq soln) (100 mL) 52 PDA.HCl (92.0 g of 57% aq soln), IPA 75° C. 18 87 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (4.77 mL), NaOH H2O (90 g of 50% aq soln) (100 mL) 53 PDA.HCl (92.0 g of 57% aq soln), IPA 75° C. 18 60 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (6.35 mL), NaOH H2O (90.0 g of 50% aq soln) (100 mL) 54 PDA.HCl (95.6 g of 56.8% aq soln), IPA 75° C. 18 71 1-bromodecane (62.9 g), (100 mL) 1,6-dibromohexane (3.12 mL), H2O NaOH (90.0 g of 50% aq soln) (100 mL) 55 PDA.HCl (95.6 g of 56.8% aq soln), IPA 75° C. 18 73 1-bromodecane (62.9 g), (100 mL) epichlorohydrin (1.59 mL), NaOH H2O (90 g of 50% aq soln) (100 mL) 56 PDA.HCl (54.3 g of 59% aq soln), H2O 95° C. 18 58 1-chlorodecane (50.2 g), (200 mL) epichlorohydrin (1.59 mL), NaOH (90 g of 50% aq soln) 57 PDA.HCl (100.0 g of 60% aq soln), H2O 75° C. 18 86 1-bromodecane (62.9 g), (300 mL) epichlorohydrin (4.77 mL) NaOH IPA (32.5 g of 50% aq soln) (300 mL) 58 PDMA.HCl (100.0 g of 60% aq IPA 75° C. 18 85 soln), 1-bromodecane (62.9 g), (600 mL) epichlorohydrin (4.77 mL), NaOH (32.5 g of 50% aq soln) 59 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 86 soln), 1-bromodecane (62.9 g), (600 mL) epichlorohydrin (0.318 mL), NaOH (32.5 g of 50% aq soln) 60 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 74 soln), 1-bromodecane (31.5 g), (600 mL) epichlorohydrin (4.77 mL), NaOH (32.5 g of 50% aq soln) 61 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 11 soln), 1,4-butanediol diglycidyl ether (300 mL) (11.74 mL), dodecyl/tetradecyl IPA glycidyl ether (86.4 mL), NaOH (300 mL) (32.5 g of 50% aq soln) 62 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 82 soln), 1-bromododecane (62.9 g), (300 mL) epichlorohydrin (9.54 mL), NaOH IPA (32.5 g of 50% aq soln) (300 mL) 63 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 94 soln), 1-bromododecane (125.8 g), (300 mL) epichlorohydrin (4.77 mL), NaOH IPA (32.5 g of 50% aq soln) (300 mL) 64 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 81 soln), 1-bromodecane (62.9 g), (300 mL) epichlorohydrin (9.54 mL), NaOH IPA (32.5 g of 50% aq soln) (300 mL) 65 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 91 soln), 1-bromodecane (118.0 mL), (300 mL) epichlorohydrin (4.77 mL), NaOH IPA (32.5 g of 50% aq soln) (300 mL) 66 PDMA.HCl (100.0 g of 50% aq H2O 75° C. 18 66 soln), 1-bromododecane (35.8 g), (300 mL) epichlorohydrin (9.54 mL), NaOH IPA (32.5 g of 50% aq soln) (300 mL) 67 PDMA.HCl (100.0 g of 60% aq H2O 75° C. 18 90 soln), 1-bromododecane (80.7 g), (300 mL) epichlorohydrin (1.59 mL), NaOH IPA (32.5 g of 50% aq soln) (300 mL) 68 PDMA.HCl (100.0 g of 60% aq H2O 60° C. 18 39 soln), 1-bromodecane (62.9 g), (600 mL) epichlorohydrin (4.77 mL), NaOH hexanes (32.5 g of 50% aq soln) (1200 mL) 69 PDMA.HCl (100.0 g of 60% aq toluene 75° C. 18 60 soln), 1-bromodecane (62.9 g), (600 mL) epichlorohydrin (4.77 mL), NaOH (32.5 g of 50% aq soln) 70 PDMA.HCl (100.0 g of 60% aq MeOH 60° C. 18 49 soln), 1-bromodecane (62.9 g), (600 mL) epichlorohydrin (4.77 mL), NaOH hexanes (32.5 g of 50% aq soln) (1200 mL) 71 PDMA.HCl (100.0 g of 60% aq H2O 95° C. 18 82 soln), 1-chlorodecane (50.3 g), (600 mL) epichlorohydrin (4.77 mL), NaOH (32.5 g of 50% aq soln) 72 PDMA. HCl (100.0 g of 60% aq H2O 95° C. 18 75 soln), 1-chlorodecane (65.3 g), (600 mL) epichlorohydrin (1.43 mL), NaOH (32.5 g of 50% aq soln) 73 PDMA.HCl (100.0 g of 60% aq H2O 95° C. 18 66 soln), 1-chlorodecane (32.7 g), (600 mL) epichlorohydrin (1.43 mL), NaOH (32.5 g of 50% aq soln) 74 PDMA.HCl (100.0 g of 60% aq H2O 95° C. 18 59 soln), 1-chlorodecane (16.4 g), (600 mL) epichlorohydrin (1.43 mL), NaOH (32.5 g of 50% aq soln) - While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (23)
1. A method for removing bile acids from a patient comprising the step of orally administering to the patient a therapeutically effective amount of a poly(diallylamine)polymer wherein more than 10% of the amino nitrogen atoms are substituted by a hydrophobic substituent.
2. The method of claim 1 wherein the polymer is a homopolymer.
3. The method of claim 1 wherein the polymer is a copolymer.
4. The method of claim 1 wherein the hydrophobic substituent is a normal or branched C2-C24-alkyl group.
5. The method of claim 1 wherein the polymer comprises a repeat unit of the general formula
wherein R2 is hydrogen, a substituted or unsubstituted C1-C24-alkyl group, a substituted or unsubstituted arylalkyl group or a substituted or unsubstituted aryl group; R1 is a substituted or unsubstituted C3-C24-alkyl group, a substituted or unsubstituted arylalkyl group or a substituted or unsubstituted aryl group; and X− is a pharmaceutically acceptable anion.
6. The method of claim 5 wherein X− is a conjugate base of an acid selected from the group consisting of hydrochloric acid, hydrobromic acid, citric acid, tartaric acid, lactic acid, phosphoric acid, methanesulfonic acid, acetic acid, formic acid, maleic acid, fumaric acid, malic acid, succinic acid, malonic acid, sulfuric acid, L-glutamic acid, L-aspartic acid, pyruvic acid, mucic acid, benzoic acid, glucuronic acid, oxalic acid, ascorbic acid and acetylglycine.
7. The method of claim 5 wherein R1 is a normal or branched C3-C24-alkyl group which is substituted by an amino group, an ammonium group, an amido group, a hydroxyl group, a sulfone group, a sulfoxide group or an alkoxy group.
8. The method of claim 5 wherein R1 is an alkyl group selected from the group consisting of hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl and tetradecyl.
9. The method of claim 8 wherein R2 is methyl and R1 is selected from the group consisting of octyl, decyl and dodecyl.
11. The method of claim 10 wherein R is a C3-C24-alkyl group.
12. The method of claim 11 wherein the alkyl group is selected from the group consisting of hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl and tetradecyl.
13. The method of claim 11 wherein the alkyl group is substituted by an amino group, an ammonium group, an amido group, a hydroxyl group, a sulfoxide group, a sulfone group or an alkoxy group.
14. The method of claim 1 wherein the polymer comprises a first monomer of the general formula
wherein R1 is hydrogen, a substituted or unsubstituted C1-C24-alkyl group or a substituted or unsubstituted aryl group; R2 is a substituted or unsubstituted C3-C24-alkyl group or a substituted or unsubstituted aryl group; and X− is a pharmaceutically acceptable anion; and a second monomer of the general formula
wherein R is hydrogen, a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group.
15. The method of claim 1 wherein the polymer is a crosslinked polymer.
16. The method of claim 15 wherein the polymer is crosslinked by a multifunctional co-monomer.
17. The method of claim 16 wherein the multifunctional co-monomer is selected from the group consisting of diacrylates, triacrylates, tetraacrylates, dimethacrylates, diacrylamides, dimethacrylamides, diallylacrylamides and polyvinylarenes.
18. (canceled)
19. The method of claim 16 wherein the multifunctional comonomer is a multifunctional diallylamine.
20. (canceled)
21. (canceled)
22. The method of claim 15 wherein the polymer is crosslinked by a bridging unit selected from the group consisting of straight chain or branched, substituted or unsubstituted alkylene groups, diacylalkylene groups, diacylarene groups and alkylene bis(carbamoyl) groups.
23-55. (canceled)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/498,309 US20070190021A1 (en) | 1996-12-30 | 2006-08-01 | Poly(diallylamine)-based bile acid sequestrants |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/777,408 US6203785B1 (en) | 1996-12-30 | 1996-12-30 | Poly(diallylamine)-based bile acid sequestrants |
| PCT/US1997/023899 WO1998029107A2 (en) | 1996-12-30 | 1997-12-29 | Poly(diallylamine)-based bile acid sequestrants |
| US09/286,341 US6610283B1 (en) | 1996-12-30 | 1999-04-05 | Poly(diallylamine)-based bile acid sequestrants |
| US10/647,665 US7125547B2 (en) | 1996-12-30 | 2003-08-25 | Poly(diallylamine)-based bile acid sequestrants |
| US11/498,309 US20070190021A1 (en) | 1996-12-30 | 2006-08-01 | Poly(diallylamine)-based bile acid sequestrants |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/647,665 Continuation US7125547B2 (en) | 1996-12-30 | 2003-08-25 | Poly(diallylamine)-based bile acid sequestrants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20070190021A1 true US20070190021A1 (en) | 2007-08-16 |
Family
ID=25110177
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/777,408 Expired - Lifetime US6203785B1 (en) | 1996-12-30 | 1996-12-30 | Poly(diallylamine)-based bile acid sequestrants |
| US09/286,341 Expired - Lifetime US6610283B1 (en) | 1996-12-30 | 1999-04-05 | Poly(diallylamine)-based bile acid sequestrants |
| US10/647,665 Expired - Fee Related US7125547B2 (en) | 1996-12-30 | 2003-08-25 | Poly(diallylamine)-based bile acid sequestrants |
| US11/498,309 Abandoned US20070190021A1 (en) | 1996-12-30 | 2006-08-01 | Poly(diallylamine)-based bile acid sequestrants |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/777,408 Expired - Lifetime US6203785B1 (en) | 1996-12-30 | 1996-12-30 | Poly(diallylamine)-based bile acid sequestrants |
| US09/286,341 Expired - Lifetime US6610283B1 (en) | 1996-12-30 | 1999-04-05 | Poly(diallylamine)-based bile acid sequestrants |
| US10/647,665 Expired - Fee Related US7125547B2 (en) | 1996-12-30 | 2003-08-25 | Poly(diallylamine)-based bile acid sequestrants |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US6203785B1 (en) |
| EP (1) | EP1094801A2 (en) |
| JP (1) | JP2002512598A (en) |
| KR (1) | KR20000069826A (en) |
| CN (1) | CN1245425A (en) |
| AU (1) | AU724507B2 (en) |
| CA (1) | CA2276394A1 (en) |
| IL (1) | IL130648A0 (en) |
| NZ (1) | NZ336440A (en) |
| WO (1) | WO1998029107A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015192030A1 (en) | 2014-06-13 | 2015-12-17 | United Therapeutics Corporation | Treprostinil formulations |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5929184A (en) * | 1993-06-02 | 1999-07-27 | Geltex Pharmaceuticals, Inc. | Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants |
| US6129910A (en) * | 1993-06-02 | 2000-10-10 | Geltex Pharmaceuticals, Inc. | Water-insoluble noncrosslinked bile acid sequestrants |
| US6203785B1 (en) * | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
| US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| GB9816171D0 (en) | 1998-07-25 | 1998-09-23 | Secr Defence | Monomers and network polymers obtained therefrom |
| US6271264B1 (en) | 1998-12-01 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
| AU3988099A (en) * | 1999-05-13 | 2000-12-05 | Geltex Pharmaceuticals, Inc. | Combination therapy for treating hypercholesterolemia |
| AU3990399A (en) * | 1999-05-13 | 2000-12-05 | Geltex Pharmaceuticals, Inc. | Combination therapy for treating hypercholesterolemia |
| EP1196181A1 (en) * | 1999-07-14 | 2002-04-17 | Geltex Pharmaceuticals, Inc. | Fat-binding polymers, optionally combined with lipase inhibitors |
| US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
| US20020054903A1 (en) * | 1999-10-19 | 2002-05-09 | Joseph Tyler | Direct compression polymer tablet core |
| GB9927088D0 (en) * | 1999-11-17 | 2000-01-12 | Secr Defence | Use of poly(diallylamine) polymers |
| AT409629B (en) * | 2000-09-14 | 2002-09-25 | Dsm Fine Chem Austria Gmbh | WASHING METHOD FOR CLEANING N-BZW. POLYMERS CONTAINING AMINO OR AMMONIUM GROUPS |
| WO2002085379A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for improving vascular access in patients with vascular shunts |
| BR0209124A (en) * | 2001-04-18 | 2005-02-09 | Genzyme Corp | Method for treating a syndrome x or inhibiting the onset of symptoms of syndrome x and use of a therapeutically effective amount of a salt of at least one aliphatic amine polymer |
| DE60212819T2 (en) * | 2001-04-18 | 2006-11-23 | Genzyme Corp., Cambridge | SALT FORM POLYALLYLAMINE |
| DK1392331T3 (en) * | 2001-04-18 | 2008-06-23 | Genzyme Corp | Use of colesevelam or sevelamer, hydrogen chloride for lowering serum glucose levels |
| EP1923064B1 (en) | 2001-04-18 | 2017-06-28 | Genzyme Corporation | Use of amine polymer for lowering serum glucose |
| WO2002085380A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for treating gout and reducing serum uric acid |
| US7041280B2 (en) * | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
| US7544649B2 (en) * | 2002-02-22 | 2009-06-09 | Kao Corporation | Antifouling detergent for hard surfaces |
| AT411463B (en) | 2002-09-03 | 2004-01-26 | Dsm Fine Chem Austria Gmbh | High yield production of alkylated nitrogen containing crosslinked polymer gels, e.g. epichlorohydrin crosslinked poly allylamine hydrochloride, comprises washing with methanol, sodium chloride and water |
| AU2003282867A1 (en) * | 2002-10-22 | 2004-05-13 | Genzyme Corporation | Amine polymers for promoting bone formation |
| US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
| EP1869090A1 (en) * | 2005-03-16 | 2007-12-26 | Council Of Scientific And Industrial Research | An improved process for the preparation of crosslinked polyallylamine polymer. |
| US8986669B2 (en) * | 2005-09-02 | 2015-03-24 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
| AR056499A1 (en) * | 2005-09-06 | 2007-10-10 | Serapis Farmaceuticals Ltd | COMPOUNDS |
| CN103027896B (en) | 2005-09-15 | 2016-01-20 | 基酶有限公司 | The sachet formulation of amine polymer |
| KR101402024B1 (en) * | 2005-11-14 | 2014-06-19 | 시바 홀딩 인코포레이티드 | Functionalized cationic polymers and their use in personal care |
| JP2009536246A (en) * | 2006-05-05 | 2009-10-08 | ゲンズイメ コーポレーション | Amine condensation polymers as phosphate scavengers. |
| JP2009543869A (en) * | 2006-07-18 | 2009-12-10 | ゲンズイメ コーポレーション | Amine dendrimer |
| WO2008042222A2 (en) | 2006-09-29 | 2008-04-10 | Genzyme Corporation | Amide dendrimer compositions |
| JP5000260B2 (en) * | 2006-10-19 | 2012-08-15 | AzエレクトロニックマテリアルズIp株式会社 | Method for forming fine pattern and resist substrate processing liquid used therefor |
| JP2008102343A (en) * | 2006-10-19 | 2008-05-01 | Az Electronic Materials Kk | Developed resist substrate processing solution and resist substrate processing method using the same |
| WO2008076242A1 (en) * | 2006-12-14 | 2008-06-26 | Genzyme Corporation | Amido-amine polymer compositions |
| WO2008103368A1 (en) * | 2007-02-23 | 2008-08-28 | Genzyme Corporation | Amine polymer compositions |
| EP2131820A1 (en) * | 2007-03-08 | 2009-12-16 | Genzyme Corporation | Sulfone polymer compositions |
| EP2134169A2 (en) | 2007-03-09 | 2009-12-23 | Indigene Pharmaceuticals Inc. | Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications |
| US20100166696A1 (en) * | 2007-04-27 | 2010-07-01 | Dhal Pradeep K | Amido-amine dendrimer compositions |
| JP2011506449A (en) * | 2007-12-14 | 2011-03-03 | ジェンザイム コーポレーション | Coating pharmaceutical composition |
| WO2009154747A1 (en) * | 2008-06-20 | 2009-12-23 | Genzyme Corporation | Pharmaceutical compositions |
| JP5306755B2 (en) * | 2008-09-16 | 2013-10-02 | AzエレクトロニックマテリアルズIp株式会社 | Substrate processing liquid and resist substrate processing method using the same |
| JP5285000B2 (en) * | 2010-02-23 | 2013-09-11 | 富士フイルム株式会社 | Method for measuring low density lipoprotein cholesterol |
Citations (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2874132A (en) * | 1956-11-02 | 1959-02-17 | Rohm & Haas | Anion-exchange resins for sugar decolorization and their preparation |
| US3288770A (en) * | 1962-12-14 | 1966-11-29 | Peninsular Chem Res Inc | Water soluble quaternary ammonium polymers |
| US3308020A (en) * | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
| US3383281A (en) * | 1961-09-22 | 1968-05-14 | Merck & Co Inc | Method for binding bile acids in vivo |
| US3562266A (en) * | 1969-05-26 | 1971-02-09 | Montedison Spa | Quaternary ammonium halides having a 2-chloro cyclohexyl or 2-chloro alkyl substituent |
| US3585118A (en) * | 1968-11-18 | 1971-06-15 | Nitto Boseki Co Ltd | Process for the bulk photocopolymerization of polyaminesulfones |
| US3692895A (en) * | 1970-09-08 | 1972-09-19 | Norman A Nelson | Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria |
| US3780171A (en) * | 1969-12-27 | 1973-12-18 | Merck Patent Gmbh | Ingestible polymeric compositions |
| US3787474A (en) * | 1969-09-12 | 1974-01-22 | Inveresk Res Int | Cross-linked polymers |
| US3801641A (en) * | 1966-05-31 | 1974-04-02 | Ciba Geigy Corp | Quaternary ammonium salts |
| US3803237A (en) * | 1969-11-03 | 1974-04-09 | Upjohn Co | Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds |
| US3833531A (en) * | 1970-04-22 | 1974-09-03 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and salts thereof and their use in paper |
| US3840504A (en) * | 1970-01-26 | 1974-10-08 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and their use in paper |
| US3941724A (en) * | 1973-08-09 | 1976-03-02 | Ici Australia Limited | Production of amphoteric resins in a reaction medium comprising formic acid |
| US3980770A (en) * | 1971-06-04 | 1976-09-14 | Pharmacia Aktiebolag | Polymerization products containing amino groups useful in serum cholesterol level control |
| US4027009A (en) * | 1973-06-11 | 1977-05-31 | Merck & Co., Inc. | Compositions and methods for depressing blood serum cholesterol |
| US4071478A (en) * | 1976-06-07 | 1978-01-31 | Merck & Co., Inc. | Controlled partially cross-linked 3,3-ionenes |
| US4098726A (en) * | 1975-04-23 | 1978-07-04 | Merck & Co., Inc. | Poly[{alkyl-(3-ammoniopropyl)iminio}trimethylene dihalides] and process |
| US4101461A (en) * | 1974-02-08 | 1978-07-18 | Czechoslovenska Akademie Ved | Method for preparation of anion exchangers by substitution of hydrophilic polymeric gels |
| US4111859A (en) * | 1974-02-13 | 1978-09-05 | Ceskoslovenska Akademie Ved | Method of preparation of ion exchangers by alkylation and hydroxyalkylation of polymeric hydrophilic anion exchangers |
| US4167610A (en) * | 1976-12-13 | 1979-09-11 | Ici Australia Limited | Ion exchange products and processes using crosslinked allylamine copolymers |
| US4205064A (en) * | 1973-06-11 | 1980-05-27 | Merck & Co., Inc. | Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides] |
| US4217429A (en) * | 1973-06-11 | 1980-08-12 | Merck & Co., Inc. | Poly-[(methylimino)trimethylene] |
| US4287172A (en) * | 1977-09-23 | 1981-09-01 | L'oreal | Cosmetic compositions for the hair and the skin, based on polymers which contain amino groups and recurring units having a cyclic structure |
| US4340585A (en) * | 1978-12-21 | 1982-07-20 | Alfa Farmaceutici, S.P.A. | Salified anionic resin for cholesterol and lipid lowering |
| US4360434A (en) * | 1981-01-15 | 1982-11-23 | Teijin Limited | Amphoteric ion-permeable composite membrane |
| US4426489A (en) * | 1980-02-21 | 1984-01-17 | The Dow Chemical Company | Surface active polymeric surfactants containing side chain hydrophobes |
| US4540760A (en) * | 1984-01-11 | 1985-09-10 | Nitto Boseki Co. Ltd. | Process for producing polymers of monoallylamine |
| US4557930A (en) * | 1982-01-18 | 1985-12-10 | Mitsubishi Petrochemical Co., Ltd. | Anticholesteremic anion exchange resins |
| US4559391A (en) * | 1983-11-14 | 1985-12-17 | Nitto Boseki Co., Ltd. | Process for producing poly(allylamine) derivatives |
| US4605701A (en) * | 1983-10-25 | 1986-08-12 | Nitto Boseki Co., Ltd. | Small-globular crosslinked monoallylamine polymer and process for producing the same |
| US4680360A (en) * | 1983-11-14 | 1987-07-14 | Nitto Boseki Co., Ltd | Process for producing poly(allylamine) derivatives |
| US4759923A (en) * | 1987-06-25 | 1988-07-26 | Hercules Incorporated | Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives |
| US4812540A (en) * | 1983-10-21 | 1989-03-14 | Nitto Boseki Co., Ltd. | Preparation of polymers of monoallylamine and diallylamine derivatives with azo catalyst |
| US5055197A (en) * | 1991-04-05 | 1991-10-08 | Rohm And Haas Company | Process for removing residual monomers and oligemers from amine-containing polymers |
| US5185411A (en) * | 1991-01-17 | 1993-02-09 | The Dow Chemical Company | Polymerization of water-soluble monomers |
| US5189111A (en) * | 1988-01-07 | 1993-02-23 | Sandoz Ltd. | Aminoalkylated side-chains-containing vinylic copolymers |
| US5236701A (en) * | 1989-07-19 | 1993-08-17 | Lowchol Scientific Inc. | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
| US5414068A (en) * | 1994-01-24 | 1995-05-09 | Rohm And Haas Company | Crosslinked anion exchange particles and method for producing the particles |
| US5428112A (en) * | 1992-07-22 | 1995-06-27 | Hoechst Aktiengesellschaft | Crosslinked, nitrogen-containing vinyl copolymers, processes for their preparation and the use of these compounds |
| US5430110A (en) * | 1992-07-22 | 1995-07-04 | Hoechst Aktiengesellschaft | Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary |
| US5451397A (en) * | 1992-12-21 | 1995-09-19 | Rohm And Haas Company | Bile acid sequestrant |
| US5462730A (en) * | 1990-12-04 | 1995-10-31 | Imperial Chemical Industries Plc | Cross-linked quaternary ammonium derivatives of poly(N, N-dialkylallyl) ammonium polymers |
| US6203785B1 (en) * | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB798488A (en) | 1956-01-09 | 1958-07-23 | Nat Aluminate Corp | Quaternary ammonium compounds and method for the preparation thereof |
| BE580490A (en) | 1958-07-15 | 1960-01-08 | Merck & Co Inc | Compositions and methods for lowering the cholesterol content of the blood |
| FI67483C (en) | 1977-02-17 | 1985-04-10 | Merck & Co Inc | PROCEDURE FOR THE FRAMEWORK OF ETHCYCLE ADMINISTRATION OF PHARMACOLOGICAL PRODUCT AGAINST GALLSYRAK COMPLEX BILDANDE ADSORBATE PREPARATION |
| JPS5610531A (en) | 1979-07-06 | 1981-02-03 | Teijin Ltd | Selectively ion-permeable composite membrane and production thereof |
| JPS5747302A (en) | 1980-09-03 | 1982-03-18 | Mitsubishi Petrochem Co Ltd | Preparation of crosslinkable electrolytic polymer |
| GB2090605B (en) | 1980-12-12 | 1984-09-05 | Smith & Nephew Ass | Polymer of diallyl ammonium monomers pharmaceutical compositions thereof |
| JPS57125233A (en) | 1981-01-28 | 1982-08-04 | Karupu Kogyo Kk | Resin composition for prescription envelop container |
| JPS5879022A (en) | 1981-11-04 | 1983-05-12 | Bitamin Kenkyusho:Kk | Novel metal-crosslinked polymer compound containing quaternary nitrogen atom, its preparation, and remedy for hyperlipemia containing said polymer compound as active component |
| EP0162388B1 (en) | 1984-05-11 | 1989-09-13 | Bristol-Myers Company | Novel bile sequestrant resin and uses |
| JPH073035B2 (en) | 1986-01-14 | 1995-01-18 | 東レ株式会社 | Cloth for dyeing ink jet and its dyeing method |
| JPS62257481A (en) | 1986-04-30 | 1987-11-10 | 三洋化成工業株式会社 | Dye fixing agent |
| GB2202872A (en) | 1987-02-13 | 1988-10-05 | Grace W R & Co | Pitch control aid and dye assistant |
| JPH021358A (en) | 1988-03-01 | 1990-01-05 | Sanyo Chem Ind Ltd | Chemical for ink jet recording paper |
| GB8829088D0 (en) | 1988-12-13 | 1989-01-25 | Smith Kline French Lab | Compounds |
| CA2007641A1 (en) | 1989-02-01 | 1990-08-01 | Donald S. Karanewsky | Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination |
| CA2016467A1 (en) | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
| GB8928278D0 (en) | 1989-12-14 | 1990-02-21 | Smith Kline French Lab | Compounds |
| CA2040996A1 (en) | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
| GB9011332D0 (en) | 1990-05-21 | 1990-07-11 | Smith Kline French Lab | Compounds |
| JPH08500386A (en) | 1992-08-20 | 1996-01-16 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | Crosslinked polymer ammonium salt |
| WO1994027620A1 (en) | 1993-06-02 | 1994-12-08 | Geltex Pharmaceuticals, Inc. | Compositions and process for removing bile salts |
| US5624963A (en) | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
| JPH07316061A (en) | 1994-05-23 | 1995-12-05 | Sekisui Chem Co Ltd | Cholesterol lowering agent |
| TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
-
1996
- 1996-12-30 US US08/777,408 patent/US6203785B1/en not_active Expired - Lifetime
-
1997
- 1997-12-29 WO PCT/US1997/023899 patent/WO1998029107A2/en not_active Ceased
- 1997-12-29 KR KR1019997005988A patent/KR20000069826A/en not_active Withdrawn
- 1997-12-29 EP EP97952646A patent/EP1094801A2/en not_active Withdrawn
- 1997-12-29 AU AU56210/98A patent/AU724507B2/en not_active Ceased
- 1997-12-29 NZ NZ336440A patent/NZ336440A/en unknown
- 1997-12-29 JP JP53022198A patent/JP2002512598A/en active Pending
- 1997-12-29 CA CA002276394A patent/CA2276394A1/en not_active Abandoned
- 1997-12-29 CN CN97181611A patent/CN1245425A/en active Pending
- 1997-12-29 IL IL13064897A patent/IL130648A0/en unknown
-
1999
- 1999-04-05 US US09/286,341 patent/US6610283B1/en not_active Expired - Lifetime
-
2003
- 2003-08-25 US US10/647,665 patent/US7125547B2/en not_active Expired - Fee Related
-
2006
- 2006-08-01 US US11/498,309 patent/US20070190021A1/en not_active Abandoned
Patent Citations (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2874132A (en) * | 1956-11-02 | 1959-02-17 | Rohm & Haas | Anion-exchange resins for sugar decolorization and their preparation |
| US3308020A (en) * | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
| US3383281A (en) * | 1961-09-22 | 1968-05-14 | Merck & Co Inc | Method for binding bile acids in vivo |
| US3288770A (en) * | 1962-12-14 | 1966-11-29 | Peninsular Chem Res Inc | Water soluble quaternary ammonium polymers |
| US3801641A (en) * | 1966-05-31 | 1974-04-02 | Ciba Geigy Corp | Quaternary ammonium salts |
| US3585118A (en) * | 1968-11-18 | 1971-06-15 | Nitto Boseki Co Ltd | Process for the bulk photocopolymerization of polyaminesulfones |
| US3562266A (en) * | 1969-05-26 | 1971-02-09 | Montedison Spa | Quaternary ammonium halides having a 2-chloro cyclohexyl or 2-chloro alkyl substituent |
| US3787474A (en) * | 1969-09-12 | 1974-01-22 | Inveresk Res Int | Cross-linked polymers |
| US3803237A (en) * | 1969-11-03 | 1974-04-09 | Upjohn Co | Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds |
| US3780171A (en) * | 1969-12-27 | 1973-12-18 | Merck Patent Gmbh | Ingestible polymeric compositions |
| US3840504A (en) * | 1970-01-26 | 1974-10-08 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and their use in paper |
| US3833531A (en) * | 1970-04-22 | 1974-09-03 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and salts thereof and their use in paper |
| US3692895A (en) * | 1970-09-08 | 1972-09-19 | Norman A Nelson | Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria |
| US3980770A (en) * | 1971-06-04 | 1976-09-14 | Pharmacia Aktiebolag | Polymerization products containing amino groups useful in serum cholesterol level control |
| US4217429A (en) * | 1973-06-11 | 1980-08-12 | Merck & Co., Inc. | Poly-[(methylimino)trimethylene] |
| US4205064A (en) * | 1973-06-11 | 1980-05-27 | Merck & Co., Inc. | Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides] |
| US4027009A (en) * | 1973-06-11 | 1977-05-31 | Merck & Co., Inc. | Compositions and methods for depressing blood serum cholesterol |
| US3941724A (en) * | 1973-08-09 | 1976-03-02 | Ici Australia Limited | Production of amphoteric resins in a reaction medium comprising formic acid |
| US4101461A (en) * | 1974-02-08 | 1978-07-18 | Czechoslovenska Akademie Ved | Method for preparation of anion exchangers by substitution of hydrophilic polymeric gels |
| US4111859A (en) * | 1974-02-13 | 1978-09-05 | Ceskoslovenska Akademie Ved | Method of preparation of ion exchangers by alkylation and hydroxyalkylation of polymeric hydrophilic anion exchangers |
| US4098726A (en) * | 1975-04-23 | 1978-07-04 | Merck & Co., Inc. | Poly[{alkyl-(3-ammoniopropyl)iminio}trimethylene dihalides] and process |
| US4071478A (en) * | 1976-06-07 | 1978-01-31 | Merck & Co., Inc. | Controlled partially cross-linked 3,3-ionenes |
| US4167610A (en) * | 1976-12-13 | 1979-09-11 | Ici Australia Limited | Ion exchange products and processes using crosslinked allylamine copolymers |
| US4287172A (en) * | 1977-09-23 | 1981-09-01 | L'oreal | Cosmetic compositions for the hair and the skin, based on polymers which contain amino groups and recurring units having a cyclic structure |
| US4340585A (en) * | 1978-12-21 | 1982-07-20 | Alfa Farmaceutici, S.P.A. | Salified anionic resin for cholesterol and lipid lowering |
| US4426489A (en) * | 1980-02-21 | 1984-01-17 | The Dow Chemical Company | Surface active polymeric surfactants containing side chain hydrophobes |
| US4360434A (en) * | 1981-01-15 | 1982-11-23 | Teijin Limited | Amphoteric ion-permeable composite membrane |
| US4557930A (en) * | 1982-01-18 | 1985-12-10 | Mitsubishi Petrochemical Co., Ltd. | Anticholesteremic anion exchange resins |
| US4812540A (en) * | 1983-10-21 | 1989-03-14 | Nitto Boseki Co., Ltd. | Preparation of polymers of monoallylamine and diallylamine derivatives with azo catalyst |
| US4605701A (en) * | 1983-10-25 | 1986-08-12 | Nitto Boseki Co., Ltd. | Small-globular crosslinked monoallylamine polymer and process for producing the same |
| US4680360A (en) * | 1983-11-14 | 1987-07-14 | Nitto Boseki Co., Ltd | Process for producing poly(allylamine) derivatives |
| US4559391A (en) * | 1983-11-14 | 1985-12-17 | Nitto Boseki Co., Ltd. | Process for producing poly(allylamine) derivatives |
| US4540760A (en) * | 1984-01-11 | 1985-09-10 | Nitto Boseki Co. Ltd. | Process for producing polymers of monoallylamine |
| US4759923A (en) * | 1987-06-25 | 1988-07-26 | Hercules Incorporated | Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives |
| US5189111A (en) * | 1988-01-07 | 1993-02-23 | Sandoz Ltd. | Aminoalkylated side-chains-containing vinylic copolymers |
| US5374422A (en) * | 1989-07-19 | 1994-12-20 | Lowchol Scientific, Inc. | Ingestible [hydrophobic] polymeric amines useful for lowering blood cholesterol |
| US5236701A (en) * | 1989-07-19 | 1993-08-17 | Lowchol Scientific Inc. | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
| US5462730A (en) * | 1990-12-04 | 1995-10-31 | Imperial Chemical Industries Plc | Cross-linked quaternary ammonium derivatives of poly(N, N-dialkylallyl) ammonium polymers |
| US5185411A (en) * | 1991-01-17 | 1993-02-09 | The Dow Chemical Company | Polymerization of water-soluble monomers |
| US5055197A (en) * | 1991-04-05 | 1991-10-08 | Rohm And Haas Company | Process for removing residual monomers and oligemers from amine-containing polymers |
| US5428112A (en) * | 1992-07-22 | 1995-06-27 | Hoechst Aktiengesellschaft | Crosslinked, nitrogen-containing vinyl copolymers, processes for their preparation and the use of these compounds |
| US5430110A (en) * | 1992-07-22 | 1995-07-04 | Hoechst Aktiengesellschaft | Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary |
| US5451397A (en) * | 1992-12-21 | 1995-09-19 | Rohm And Haas Company | Bile acid sequestrant |
| US5414068A (en) * | 1994-01-24 | 1995-05-09 | Rohm And Haas Company | Crosslinked anion exchange particles and method for producing the particles |
| US6203785B1 (en) * | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
| US6610283B1 (en) * | 1996-12-30 | 2003-08-26 | Genzyme Corporation | Poly(diallylamine)-based bile acid sequestrants |
| US7125547B2 (en) * | 1996-12-30 | 2006-10-24 | Genzyme Corporation | Poly(diallylamine)-based bile acid sequestrants |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015192030A1 (en) | 2014-06-13 | 2015-12-17 | United Therapeutics Corporation | Treprostinil formulations |
Also Published As
| Publication number | Publication date |
|---|---|
| US7125547B2 (en) | 2006-10-24 |
| AU5621098A (en) | 1998-07-31 |
| NZ336440A (en) | 2001-07-27 |
| CA2276394A1 (en) | 1998-07-09 |
| WO1998029107A2 (en) | 1998-07-09 |
| CN1245425A (en) | 2000-02-23 |
| US20040151687A1 (en) | 2004-08-05 |
| US6203785B1 (en) | 2001-03-20 |
| KR20000069826A (en) | 2000-11-25 |
| WO1998029107A3 (en) | 2001-03-01 |
| AU724507B2 (en) | 2000-09-21 |
| EP1094801A2 (en) | 2001-05-02 |
| IL130648A0 (en) | 2000-06-01 |
| JP2002512598A (en) | 2002-04-23 |
| US6610283B1 (en) | 2003-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7125547B2 (en) | Poly(diallylamine)-based bile acid sequestrants | |
| US6726905B1 (en) | Poly (diallylamines)-based phosphate binders | |
| US6294163B1 (en) | Polymers containing guanidinium groups as bile acid sequestrants | |
| US6248318B1 (en) | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers | |
| US6271264B1 (en) | Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants | |
| US6290947B1 (en) | Ionic polymers as toxin-binding agents | |
| EP1416942B1 (en) | Amine polymers for treating gout and binding uric acid | |
| US7229613B2 (en) | Method for lowering serum glucose | |
| US20040018169A1 (en) | Method for reducing oxalate | |
| US20020187120A1 (en) | Method for treating gout and reducing serum uric acid | |
| WO1998043653A1 (en) | Interpenetrating polymer networks for sequestration of bile acids | |
| EP1645278A2 (en) | Use of aliphatic polyamines for reducing oxalate | |
| WO2000069445A1 (en) | Combination therapy for treating hypercholesterolemia | |
| US6517825B1 (en) | Polyether-based bile acid sequestrants | |
| MXPA99006152A (en) | Poly(diallylamine)based bile acid sequestrants | |
| EP1923064B1 (en) | Use of amine polymer for lowering serum glucose | |
| MXPA00004329A (en) | Unsubstituted polydiallylamine for treating hypercholesterolemia | |
| HK1025912A (en) | Poly(diallylamine)-based bile acid sequestrants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |